JPH07101905A - Production of carboxylic acid ester derivative - Google Patents

Production of carboxylic acid ester derivative

Info

Publication number
JPH07101905A
JPH07101905A JP6207944A JP20794494A JPH07101905A JP H07101905 A JPH07101905 A JP H07101905A JP 6207944 A JP6207944 A JP 6207944A JP 20794494 A JP20794494 A JP 20794494A JP H07101905 A JPH07101905 A JP H07101905A
Authority
JP
Japan
Prior art keywords
group
substituted
compound
formula
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6207944A
Other languages
Japanese (ja)
Inventor
Masakatsu Matsumoto
正勝 松本
Nobuko Watanabe
信子 渡辺
Hideko Mori
英子 森
Hisako Kobayashi
久子 小林
Hiroshi Ikawa
博 伊川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP6207944A priority Critical patent/JPH07101905A/en
Publication of JPH07101905A publication Critical patent/JPH07101905A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To obtain two kinds of carboxylic acid ester derivatives from a heptanoic acid derivative simply in high yield useful as a starting compound for hypolipidemic medicine having inhibitory action on 3-hydroxy-3- methylglutaryl-CoA reductase, an intermediate, etc. CONSTITUTION:A heptanoic acid of formula I (R<1> and R<2> are OH-protecting group or R<1> and R<2> are bonded to from OH-protecting group; R<3> is 1-12C alkyl or aryll is reacted with an organometallic reagent derived from a halogen compound of the formula R<4>-X<1> (R<4> is substituted aryl, substituted heterocyclic, substituted vinyl or substituted cycloalkenyl; X<1> is halogen) to give a carboxylic acid ester derivative of formula II. Further, the carboxylic acid ester derivative of formula II is dehydrated to give a carboxylic acid ester derivative of formula III. An organolithium compound or an organomagnesium halide compound is preferable as the organometallic reagent. The dehydration is preferably carried out in the presence of a halogenation reagent, a sulfonation reagent or an esterification reagent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は一般式FIELD OF THE INVENTION The present invention has the general formula

【化8】 (式中、R1 及びR2 は、水酸基の保護基又はR1 、R
2 が一体となった水酸基の保護基、R3 は炭素数1〜1
2のアルキル基又はアリール基であり、R4 は置換アリ
ール基、置換複素環基、置換ビニル基又は置換シクロア
ルケニル基である。)で表されるカルボン酸エステル誘
導体及び一般式
[Chemical 8] (In the formula, R 1 and R 2 are a hydroxyl-protecting group or R 1 , R 2
Hydroxyl protecting group in which 2 is integrated, R 3 has 1 to 1 carbon atoms
2 is an alkyl group or an aryl group, and R 4 is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group or a substituted cycloalkenyl group. ) Carboxylic acid ester derivative represented by

【化9】 (式中、R1 、R2 、R3 及びR4 は前記と同じであ
る。)で表されるカルボン酸エステル誘導体の製造方法
に関する。前記一般式(II)で表されるカルボン酸エス
テル誘導体は、とりわけ脱保護反応等に付することによ
り3−ヒドロキシ−3−メチルグルタリル−CoA還元
酵素(以下HMG−CoA還元酵素という。)阻害作用
を有する抗高脂血症剤に誘導することができる。
[Chemical 9] (In the formula, R 1 , R 2 , R 3 and R 4 are the same as the above.) The present invention relates to a method for producing a carboxylic acid ester derivative. The carboxylic acid ester derivative represented by the general formula (II) is inhibited by 3-hydroxy-3-methylglutaryl-CoA reductase (hereinafter referred to as HMG-CoA reductase) by subjecting it to a deprotection reaction. It can be induced into an antihyperlipidemic agent having an action.

【0002】[0002]

【従来の技術】合成HMG−CoA還元酵素阻害剤であ
る7位置換−(E)−3,5−ジヒドロキシ−6−ヘプ
テン酸構造を有する化合物の合成法は、光学活性体の合
成を含めて多数の方法が報告されている。7位置換−
(E)−3,5−ジヒドロキシ−6−ヘプテン酸化合物
において活性発現の鍵となる7位置換基は置換アリール
基、置換複素環基、置換ビニル基、置換シクロアルケニ
ル基等であり、この7位置換基に3,5−ジヒドロキシ
−6−ヘプテン酸ユニットを導入する方法としては大別
して次の3つの方法が知られている。
2. Description of the Related Art A synthetic HMG-CoA reductase inhibitor, a compound having a 7-substituted- (E) -3,5-dihydroxy-6-heptenoic acid structure, includes synthetic methods of optically active compounds. Many methods have been reported. 7-position substitution-
In the (E) -3,5-dihydroxy-6-heptenoic acid compound, the 7-position substituent that is the key to the activity expression is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group, a substituted cycloalkenyl group or the like. As a method of introducing a 3,5-dihydroxy-6-heptenoic acid unit into a position substituent, the following three methods are roughly known.

【0003】(I)7位置換基構造にC3炭素鎖を導入
したのち残りのC4炭素鎖を導入する方法。C3炭素鎖
として2−プロペナールまたは2−プロペン酸誘導体を
利用した方法であり、 C4炭素鎖としてβ−ケトエステルを導入する方法
(J.Med.Chem.1986,29,170,
J.Org.Chem.1991,56,5752) 、
不斉誘起を行うC2炭素鎖を導入後さらにC2炭素鎖
を導入する方法(Tetrahedron Lett,
1984,25,5031)、およびイソアスコルビ
ン酸より複雑な工程を経て合成した光学活性C4炭素鎖
を導入する方法(Tetrahedron Lett,
1985,26,2951,)等がある。
(I) A method of introducing a C3 carbon chain into the 7-position substituent structure and then introducing the remaining C4 carbon chain. A method using 2-propenal or a 2-propenoic acid derivative as a C3 carbon chain, and a method of introducing a β-ketoester as a C4 carbon chain (J. Med. Chem. 1986 , 29, 170,
J. Org. Chem. 1991 , 56, 5752),
A method of introducing a C2 carbon chain for asymmetric induction and then introducing a C2 carbon chain (Tetrahedron Lett,
1984 , 25, 5031), and a method for introducing an optically active C4 carbon chain synthesized through a more complicated process than isoascorbic acid (Tetrahedron Lett,
1985 , 26, 2951,).

【0004】(II)7位置換基構造にC1炭素鎖を導入
して残りのC6炭素鎖を導入する方法。 7位置換基構造に導入したホルミル基とC6炭素鎖よ
りなる光学活性なHorner−Emmons試薬を反
応させる方法(J.Med.Chem.1987,3
0,1858) 、7位置換基構造に導入した置換スル
フィニルメチル基を利用する方法(Tetrahedr
on Lett.1985,25,2947) 、7位
置換基構造に導入したハロメチル基より変換したWit
tig試薬あるいはHorner−Emmons試薬を
利用する方法(Tetrahedron Lett.
982,23,4305,Tetrahedron L
ett.1990,31,2545) 等がある。
(II) A method of introducing a C1 carbon chain into the 7-position substituent structure and introducing the remaining C6 carbon chain. A method of reacting an optically active Horner-Emmons reagent composed of a C6 carbon chain with a formyl group introduced into the 7-position substituent structure (J. Med. Chem. 1987 , 3).
0,1858), a method utilizing a substituted sulfinylmethyl group introduced into the 7-position substituent structure (Tetrahedr
on Lett. 1985 , 25, 2947), Wit converted from a halomethyl group introduced into the 7-position substituent structure.
Method using Tig reagent or Horner-Emmons reagent (Tetrahedron Lett. 1
982 , 23, 4305, Tetrahedron L
ett. 1990 , 31, 2545).

【0005】(III)7位置換基構造に直接C7炭素鎖を
導入する方法、7位置換基のハロゲン化合物を利用した
方法であり、 末端に炭素−炭素不飽和結合を有するC7炭素鎖との
Heck反応による方法(J.Med.Chem.19
90,33,31)、C7炭素鎖のシリル置換エポキ
シ化合物とハロゲン化合物より調製できる有機金属試薬
との反応およびこのシリル置換エポキシ化合物から合成
できる、スズオレフィン化合物とのHeck型の反応
による方法(Tetrahedron Lett.19
92,33,4183) 等がある。
(III) A method of directly introducing a C7 carbon chain into the 7-position substituent structure and a method of utilizing a halogen compound of the 7-position substituent, which comprises a C7 carbon chain having a carbon-carbon unsaturated bond at the terminal. Method by Heck reaction (J. Med. Chem. 19
90 , 33, 31), a reaction of a C7 carbon chain silyl-substituted epoxy compound with an organometallic reagent that can be prepared from a halogen compound, and a Heck-type reaction with a tin olefin compound that can be synthesized from this silyl-substituted epoxy compound (Tetrahedron). Lett. 19
92 , 33, 4183) and the like.

【0006】[0006]

【発明が解決しようとする課題】前記(I)−、、
、及び(II)−の方法は、目的化合物合成の最終に
近い段階において再現性等に問題の生じ易い還元反応を
行う必要がある。(II)−の方法はC6炭素鎖導入後
の工程数が多く煩雑であり、(II)−の方法はWit
tig試薬およびHorner−Emmons試薬の合
成に多段階の工程を必要とする他、Wittig反応お
よびHorner−Emmons反応自体の収率等に問
題がある。(III)−、の方法は、高価なパラジウム
試薬を使用しなければならず、また(III)−で使用す
るシリル置換エポキシ化合物を製造するためには煩雑な
工程を必要とする等(I)〜(III)の何れも工業的な製
造方法として採用するには満足できるものでない。
DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention (I)-,,
The methods (1) and (II) -need to carry out a reduction reaction which tends to cause problems in reproducibility and the like in the final stage of the synthesis of the target compound. The method (II)-has many steps after the introduction of the C6 carbon chain and is complicated, and the method (II)-is Wit.
In addition to the multi-step process required for the synthesis of the Tig reagent and the Horner-Emmons reagent, there are problems in the yield of the Wittig reaction and the Horner-Emmons reaction itself. The method (III)-requires the use of an expensive palladium reagent, and requires a complicated step for producing the silyl-substituted epoxy compound used in (III)-, etc. (I) None of (III) to (III) is satisfactory to be adopted as an industrial production method.

【0007】[0007]

【課題を解決するための手段】本発明者等は、従来の欠
点を克服すべく鋭意検討した結果、前記一般式(I)及
び(II)で表されるカルボン酸エステル誘導体を簡便に
しかも収率よく製造する方法を見い出し本発明を完成し
た。
Means for Solving the Problems As a result of intensive studies made by the present inventors to overcome the drawbacks of the prior art, the inventors have simply and easily obtained the carboxylic acid ester derivatives represented by the general formulas (I) and (II). The method of manufacturing efficiently was found, and the present invention was completed.

【0008】本発明は、一般式The present invention has the general formula

【化10】 (式中R1 、R2 及びR3 は前記と同じである。)で表
されるヘプタン酸誘導体と一般式 R4 −X1 (IV) (式中R4 は前記と同じであり、X1 はハロゲン原子で
ある。)で表されるハロゲン化合物から誘導される有機
金属試薬とを反応させ、一般式
[Chemical 10] (Wherein R 1 , R 2 and R 3 are the same as above) and a general formula R 4 —X 1 (IV) (wherein R 4 is the same as above, X 1 is a halogen atom), and is reacted with an organometallic reagent derived from a halogen compound represented by the general formula

【化11】 (式中、R1 、R2 、R3 及びR4 は前記と同じであ
る。)で表されるカルボン酸エステル誘導体を得、次い
で脱水反応させることにより一般式
[Chemical 11] (In the formula, R 1 , R 2 , R 3 and R 4 are the same as above.) A carboxylic acid ester derivative represented by the following formula is obtained by dehydration reaction.

【化12】 (式中、R1 、R2 、R3 及びR4 は前記と同じであ
る。)で表されるカルボン酸エステル誘導体を製造する
方法である。
[Chemical 12] (In the formula, R 1 , R 2 , R 3 and R 4 are the same as the above.).

【0009】反応に用いる前記一般式(III )で表され
るヘプタン酸誘導体は、R1 及びR2 が水酸基の保護基
であり、さらにR1 、R2 が一体となり水酸基の保護基
を形成した化合物である。保護基としては、炭素数1〜
6のアルキル基を挙げることができ、このアルキル基に
は置換基を有してもよく、置換アルキル基として例えば
メトキシメチル基、エトキシメチル基、メトキシエチル
基、ベンジル基等を挙げることができる。さらにアリル
基、メタリル基等の炭素数2〜6のアルケニル基、2−
テトラヒドロピラニル基、2−テトラヒドロチオピラニ
ル基、2−テトラヒドロフラニル基等の複素環基、トリ
メチルシリル基、t−ブチルジメチルシリル基、ジメチ
ルフェニルシリル基等の置換シリル基、ホルミル基、ア
セチル基、ベンゾイル基等のアシル基、t−ブトキシカ
ルボニル基、メトキシカルボニル基、ベンジロキシカル
ボニル基等の置換オキシカルボニル基、N−フェニルカ
ルバモイル基等の置換カルバモイル基等を挙げることが
できる。R1 及びR2 が一体となった保護基としては、
例えばメチレン基であり、さらにエチリデン基、プロピ
リデン基、イソプロピリデン基、ベンジリデン基、シク
ロペンチリデン基、シクロヘキシリデン基等の炭素数2
〜10のアルキリデン基、カルボニル基等を挙げること
ができる。
In the heptanoic acid derivative represented by the general formula (III) used in the reaction, R 1 and R 2 are hydroxyl-protecting groups, and R 1 and R 2 are united to form a hydroxyl-protecting group. It is a compound. The protecting group has 1 to 1 carbon atoms.
The alkyl group of 6 may be mentioned, and the alkyl group may have a substituent, and examples of the substituted alkyl group include a methoxymethyl group, an ethoxymethyl group, a methoxyethyl group and a benzyl group. Further, an alkenyl group having 2 to 6 carbon atoms such as an allyl group and a methallyl group, 2-
Tetrahydropyranyl group, 2-tetrahydrothiopyranyl group, heterocyclic group such as 2-tetrahydrofuranyl group, trimethylsilyl group, t-butyldimethylsilyl group, substituted silyl group such as dimethylphenylsilyl group, formyl group, acetyl group, Examples thereof include an acyl group such as a benzoyl group, a substituted oxycarbonyl group such as a t-butoxycarbonyl group, a methoxycarbonyl group and a benzyloxycarbonyl group, and a substituted carbamoyl group such as an N-phenylcarbamoyl group. As the protecting group in which R 1 and R 2 are integrated,
For example, it is a methylene group, and further has 2 carbon atoms such as ethylidene group, propylidene group, isopropylidene group, benzylidene group, cyclopentylidene group and cyclohexylidene group.
Examples thereof include an alkylidene group and a carbonyl group of 10 to 10.

【0010】R3 は、炭素数1〜12好ましくは炭素数
1〜4のアルキル基又はアリール基である。このアルキ
ル基としては、直鎖状、分枝鎖状又は環状のアルキル基
であり、例えばメチル基、エチル基、プロピル基、ブチ
ル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル
基、ノニル基、デシル基、ウンデシル基、ドデシル基、
イソプロピル基、s−ブチル基、t−ブチル基、シクロ
ペンチル基、シクロヘキシル基等を挙げることができ
る。このアルキル基には置換基を有していてもよく、こ
の置換基としては例えばフェニル基、ナフチル基等のア
リール基を挙げることができる。またR3 のアリール基
としては、例えばフェニル基、ナフチル基等を挙げるこ
とができる。
R 3 is an alkyl group or aryl group having 1 to 12 carbon atoms, preferably 1 to 4 carbon atoms. The alkyl group is a linear, branched or cyclic alkyl group, for example, methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, heptyl group, octyl group, nonyl group, Decyl group, undecyl group, dodecyl group,
Examples thereof include isopropyl group, s-butyl group, t-butyl group, cyclopentyl group and cyclohexyl group. The alkyl group may have a substituent, and examples of the substituent include aryl groups such as a phenyl group and a naphthyl group. Moreover, examples of the aryl group of R 3 include a phenyl group and a naphthyl group.

【0011】前記一般式(III) で表されるヘプタン酸誘
導体は、例えば3,5−ビス(メトキシメトキシ)−7
−オキソヘプタン酸メチル、3,5−ビス(エトキシメ
トキシ)−7−オキソヘプタン酸メチル、3,5−ビス
(2−メトキシエトキシ)−7−オキソヘプタン酸メチ
ル、3,5−ジベンジルオキシ−7−オキソヘプタン酸
メチル、7−オキソ−3,5−ビス(2−プロペニルオ
キシ)ヘプタン酸メチル、3,5−ビス(2−メチル−
2−プロペニルオキシ)−7−オキソヘプタン酸メチ
ル、7−オキソ−3,5−ビス(テトラヒドロピラン−
2−イルオキシ)ヘプタン酸メチル、3,5−ビス(ト
リメチルシリルオキシ)−7−オキソヘプタン酸メチ
ル、3,5−ビス(t−ブチルジメチルシリルオキシ)
−7−オキソヘプタン酸メチル、3,5−ビス(ジメチ
ルフェニルシリルオキシ)−7−オキソヘプタン酸メチ
ル、3,5−ビス(ホルミルオキシ)−7−オキソヘプ
タン酸メチル、3,5−ジアセトキシ−7−オキソヘプ
タン酸メチル、3,5−ビス(ベンゾイルオキシ)−7
−オキソヘプタン酸メチル、3,5−ビス(t−ブトキ
シカルボニルオキシ)−7−オキソヘプタン酸メチル、
3,5−ビス(メトキシカルボニルオキシ)−7−オキ
ソヘプタン酸メチル、3,5−ビス(ベンジルオキシカ
ルボニルオキシ)−7−オキソヘプタン酸メチル、3,
5−ビス(N−フェニルカルバモイルオキシ)−7−オ
キソヘプタン酸メチル、7−オキソ−3,5−O−メチ
リデン−3,5−ジヒドロキシヘプタン酸メチル、7−
オキソ−3,5−O−エチリデン−3,5−ジヒドロキ
シヘプタン酸メチル、7−オキソ−3,5−O−イソプ
ロピリデン−3,5−ジヒドロキシヘプタン酸メチル、
7−オキソ−3,5−O−ベンジリデン−3,5−ジヒ
ドロキシヘプタン酸メチル、7−オキソ−3,5−O−
シクロペンチリデン−3,5−ジヒドロキシヘプタン酸
メチル、7−オキソ−3,5−O−シクロヘキシリデン
−3,5−ジヒドロキシヘプタン酸メチル、7−オキソ
−3,5−O−カルボニル−3,5−ジヒドロキシヘプ
タン酸メチル、7−オキソ−3,5−O−イソプロピリ
デン−3,5−ジヒドロキシヘプタン酸エチル、7−オ
キソ−3,5−O−イソプロピリデン−3,5−ジヒド
ロキシヘプタン酸プロピル、7−オキソ−3,5−O−
イソプロピリデン−3,5−ジヒドロキシヘプタン酸t
−ブチル、7−オキソ−3,5−O−イソプロピリデン
−3,5−ジヒドロキシヘプタン酸フェニル等を挙げる
ことができる。
The heptanoic acid derivative represented by the general formula (III) is, for example, 3,5-bis (methoxymethoxy) -7.
-Methyl oxoheptanoate, 3,5-bis (ethoxymethoxy) -7-oxomethyl heptanoate, methyl 3,5-bis (2-methoxyethoxy) -7-oxoheptanoate, 3,5-dibenzyloxy- Methyl 7-oxoheptanoate, methyl 7-oxo-3,5-bis (2-propenyloxy) heptanoate, 3,5-bis (2-methyl-
Methyl 2-propenyloxy) -7-oxoheptanoate, 7-oxo-3,5-bis (tetrahydropyran-
Methyl 2-yloxy) heptanoate, methyl 3,5-bis (trimethylsilyloxy) -7-oxoheptanoate, 3,5-bis (t-butyldimethylsilyloxy)
Methyl-7-oxoheptanoate, 3,5-bis (dimethylphenylsilyloxy) -7-oxoheptanoate, 3,5-bis (formyloxy) -7-oxoheptanoate, 3,5-diacetoxy- Methyl 7-oxoheptanoate, 3,5-bis (benzoyloxy) -7
-Methyl oxoheptanoate, methyl 3,5-bis (t-butoxycarbonyloxy) -7-oxoheptanoate,
Methyl 3,5-bis (methoxycarbonyloxy) -7-oxoheptanoate, methyl 3,5-bis (benzyloxycarbonyloxy) -7-oxoheptanoate, 3,
Methyl 5-bis (N-phenylcarbamoyloxy) -7-oxoheptanoate, Methyl 7-oxo-3,5-O-methylidene-3,5-dihydroxyheptanoate, 7-
Oxo-3,5-O-ethylidene-3,5-dihydroxyheptanoate methyl, 7-oxo-3,5-O-isopropylidene-3,5-dihydroxyheptanoate methyl,
Methyl 7-oxo-3,5-O-benzylidene-3,5-dihydroxyheptanoate, 7-oxo-3,5-O-
Methyl cyclopentylidene-3,5-dihydroxyheptanoate, methyl 7-oxo-3,5-O-cyclohexylidene-3,5-dihydroxyheptanoate, 7-oxo-3,5-O-carbonyl-3, Methyl 5-dihydroxyheptanoate, 7-oxo-3,5-O-isopropylidene-3,5-dihydroxyheptanoate ethyl, 7-oxo-3,5-O-isopropylidene-3,5-dihydroxyheptanoate propyl , 7-oxo-3,5-O-
Isopropylidene-3,5-dihydroxyheptanoic acid t
-Butyl, 7-oxo-3,5-O-isopropylidene-3,5-phenyl phenyl dihydroxyheptanoate and the like can be mentioned.

【0012】本反応で用いられる前記(III )で表され
るヘプタン酸誘導体は、置換基としてR9 及びR10を有
するブテン酸誘導体を原料とし、下記反応式式1に従い
製造される化合物である(下記参考例参照。)。
The heptanoic acid derivative represented by the above formula (III) used in this reaction is a compound prepared from the butenoic acid derivative having R 9 and R 10 as a substituent, according to the following reaction formula 1. (See the reference example below.).

【0013】[0013]

【化13】 (式中、R1 、R2 及びR3 は前記と同じであり、R9
及びR10は水素原子、低級アルキル基、アリール基又は
複素環基であり、R9 及びR10は一体となりシクロアル
キリデン基を形成してもよく、R11及びR12は低級アル
キル基である。)
[Chemical 13] (In the formula, R 1 , R 2 and R 3 are the same as defined above, and R 9
And R 10 are a hydrogen atom, a lower alkyl group, an aryl group or a heterocyclic group, R 9 and R 10 may together form a cycloalkylidene group, and R 11 and R 12 are a lower alkyl group. )

【0014】このR4 で表される置換アリール基、置換
複素環基、置換ビニル基又は置換シクロアルケニル基に
4−フルオロフェニル基が置換されている化合物にはH
MG−CoA還元酵素阻害作用を有する化合物が多く知
られ、それらを製造するには本発明の方法が好適である
と言える。因に、4−フルオロフェニル基で置換された
アリール基を有する化合物を例にその原料を入手するた
めの工程を説明するならば以下の如く反応式式2をもっ
て簡便に説明することができる。(下記参考例参照)。
A compound in which a 4-fluorophenyl group is substituted on the substituted aryl group, substituted heterocyclic group, substituted vinyl group or substituted cycloalkenyl group represented by R 4 is H.
Many compounds having MG-CoA reductase inhibitory action are known, and it can be said that the method of the present invention is suitable for producing them. Incidentally, if a process for obtaining the starting material is described by taking a compound having an aryl group substituted with a 4-fluorophenyl group as an example, it can be simply explained by the following reaction formula 2. (See the reference example below).

【化14】 (式中、R5 はハロゲン原子、炭素数1〜6のアルキル
基、又はR8 O−で表される基であり、R8 は水素原子
又は炭素数1〜6のアルキル基、R6 は炭素数1〜6の
アルキル基、R7 は水素原子又は炭素数1〜6のアルキ
ル基であり、さらにR8 とR6 はそれぞれ結合している
酸素原子と一体となりジオキソラン環、ジオキサン環等
の5員環又は6員環を形成してもよく、さらにR8 とR
7 はR8 が結合している酸素原子と一体となりジヒドロ
フラン環、ジヒドロピラン環等の5員環又は6員環を形
成することができ、X2 はハロゲン原子、R13は炭素数
1〜6のアルキル基又は炭素数1〜6のアルコキシ基、
Yはハロゲン原子又は置換スルホニルオキシ基であ
る。) 反応式式2に記載された一般式(V)で表されるケトン
誘導体は、4−フルオロベンズアルデヒドを原料として
用いて製造される化合物である。(下記参考例参照)。
[Chemical 14] (In the formula, R 5 is a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a group represented by R 8 O—, R 8 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 6 is An alkyl group having 1 to 6 carbon atoms, R 7 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 8 and R 6 are integrated with the oxygen atom to which they are bonded, such as a dioxolane ring or a dioxane ring. It may form a 5-membered ring or a 6-membered ring, and R 8 and R
7 can form a 5-membered ring or 6-membered ring such as a dihydrofuran ring or a dihydropyran ring together with the oxygen atom to which R 8 is bonded, X 2 is a halogen atom, and R 13 is a carbon atom having a carbon number of 1 to 1 An alkyl group having 6 or an alkoxy group having 1 to 6 carbon atoms,
Y is a halogen atom or a substituted sulfonyloxy group. The ketone derivative represented by the general formula (V) described in the reaction formula 2 is a compound produced by using 4-fluorobenzaldehyde as a raw material. (See the reference example below).

【0015】前記一般式(IV)で表されるハロゲン化合
物は、例えばアルカリ金属、アルカリ土類金属等を反応
させることにより前記有機金属試薬を製造することがで
きる。この有機金属試薬としては、例えば置換アリール
リチウム、置換複素環リチウム、置換ビニルリチウム、
置換シクロアルケニルリチウム等の有機リチウム化合
物、置換アリールマグネシウムハライド、置換複素環マ
グネシウムハライド、置換ビニルマグネシウムハライ
ド、置換シクロアルケニルマグネシウムハライド等の有
機マグネシウムハライド化合物等を挙げることができ
る。有機マグネシウムハライドを構成するハロゲン原子
は塩素、臭素、ヨウ素等を挙げることができる。
The organometallic reagent can be prepared by reacting the halogen compound represented by the general formula (IV) with, for example, an alkali metal or an alkaline earth metal. Examples of the organometallic reagent include substituted aryl lithium, substituted heterocyclic lithium, substituted vinyl lithium,
Examples thereof include organic lithium compounds such as substituted cycloalkenyl lithium, substituted aryl magnesium halides, substituted heterocyclic magnesium halides, substituted vinyl magnesium halides, substituted cycloalkenyl magnesium halides and other organic magnesium halide compounds. Examples of the halogen atom that constitutes the organomagnesium halide include chlorine, bromine, iodine and the like.

【0016】前記一般式(III )で表されるヘプタン酸
誘導体と一般式(IV)で表されるハロゲン化合物から誘
導される有機金属試薬との反応は、両者を混合すること
により行い、前記一般式(I)で表されるカルボン酸エ
ステル誘導体を製造することができる。反応を行うにあ
たっては、不活性溶媒中で行うことが望ましく、例えば
ジエチルエーテル、ジメトキシエタン(DME)、テト
ラヒドロフラン(THF)、1,4−ジオキサン、ジグ
ライム等のエーテル類を単独又は混合して用いることが
できる。
The reaction between the heptanoic acid derivative represented by the general formula (III) and the organometallic reagent derived from the halogen compound represented by the general formula (IV) is carried out by mixing the two, and The carboxylic acid ester derivative represented by the formula (I) can be produced. When carrying out the reaction, it is desirable to carry out in an inert solvent, for example, ethers such as diethyl ether, dimethoxyethane (DME), tetrahydrofuran (THF), 1,4-dioxane, diglyme are used alone or in combination. You can

【0017】反応は、通常−78〜100℃で行うこと
ができる。尚本反応を行うには無水条件下でかつ不活性
ガス、例えば窒素ガス、アルゴンガス等の雰囲気下で反
応を行うことが目的物を収率よく得るためには好まし
い。
The reaction can usually be carried out at -78 to 100 ° C. To carry out this reaction, it is preferable to carry out the reaction under anhydrous conditions and in an atmosphere of an inert gas such as nitrogen gas or argon gas in order to obtain the desired product in good yield.

【0018】次いで得られた前記一般式(I)で表され
るカルボン酸エステル誘導体は、脱水させることにより
前記一般式(II)で表されるカルボン酸エステル誘導体
を製造することができる。この脱水反応を行うにあたっ
ては、例えば塩化チオニル、臭化チオニル、五塩化リ
ン、五臭化リン等のハロゲン化試剤、塩化メタンスルホ
ニル、塩化P−トルエンスルホニル、塩化ベンゼンスル
ホニル等のスルホン化試剤、塩化アセチル、塩化プロピ
オニル、塩化ベンゾイル等のエステル化試剤等と塩基と
を組み合せた方法により行うことができる。
Then, the obtained carboxylic acid ester derivative represented by the general formula (I) can be dehydrated to produce the carboxylic acid ester derivative represented by the general formula (II). In carrying out this dehydration reaction, for example, thionyl chloride, thionyl bromide, phosphorus pentachloride, phosphorus pentabromide, etc., halogenating agents, methanesulfonyl chloride, P-toluenesulfonyl chloride, benzenesulfonyl chloride, etc. It can be carried out by a method in which an esterification agent such as acetyl, propionyl chloride or benzoyl chloride is combined with a base.

【0019】反応に用いる塩基は、例えばピリジン、ピ
コリン、コリジン、4,4−ジメチルアミノピリジン
(DMAP)、トリエチルアミン、1,5−ジアザビシ
クロ[4,3,0]ノン−5−エン(DBN)、1,8
−ジアザビシクロ[5,4,0]ウンデク−7−エン
(DBU)等の有機塩基、炭酸水素ナトリウム、炭酸水
素カリウム、炭酸ナトリウム、炭酸カリウム等の無機塩
基である。
The base used in the reaction is, for example, pyridine, picoline, collidine, 4,4-dimethylaminopyridine (DMAP), triethylamine, 1,5-diazabicyclo [4,3,0] non-5-ene (DBN), 1,8
An organic base such as diazabicyclo [5,4,0] undec-7-ene (DBU), and an inorganic base such as sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate, and potassium carbonate.

【0020】反応は、不活性溶媒中で行うことが望まし
く、例えばベンゼン、トルエン、キシレン等の芳香族炭
化水素類、ジクロロメタン、1,2−ジクロロエタン、
クロロホルム、四塩化炭素等のハロゲン化炭化水素類、
酢酸メチル、酢酸エチル等のエステル類等を単独又は混
合して用いることができる。また塩基として有機塩基を
使用する場合には不活性溶媒に換えて有機塩基を溶媒量
使用して反応を行なうこともできる。反応は、通常−3
0〜160℃で行うことができる。
The reaction is preferably carried out in an inert solvent, for example, aromatic hydrocarbons such as benzene, toluene, xylene, dichloromethane, 1,2-dichloroethane,
Halogenated hydrocarbons such as chloroform and carbon tetrachloride,
Esters such as methyl acetate and ethyl acetate can be used alone or in combination. When an organic base is used as the base, the reaction can be carried out by using the solvent amount of the organic base instead of the inert solvent. Reaction is usually -3
It can be carried out at 0 to 160 ° C.

【0021】さらに得られた前記一般式(II)で表され
るカルボン酸エステル誘導体は、例えばR1 及びR2
表される水酸基の保護基を脱保護し、所望によりR3
加水分解してHMG−CoA還元酵素阻害活性を有する
化合物を製造することができる(下記参考例参照)。
Further, the obtained carboxylic acid ester derivative represented by the general formula (II) is deprotected from the hydroxyl-protecting group represented by R 1 and R 2 , and optionally hydrolyzes R 3. Thus, a compound having HMG-CoA reductase inhibitory activity can be produced (see Reference Example below).

【0022】[0022]

【実施例】以下実施例及び参考例により本発明を更に詳
細に説明する。 参考例1 (E)−N−メトキシ−N−メチル−4−フェニル−3
−ブテンアミド
The present invention will be described in more detail with reference to the following examples and reference examples. Reference Example 1 (E) -N-methoxy-N-methyl-4-phenyl-3
-Butenamide

【化15】 [Chemical 15]

【0023】4−フェニル−3−ブテン酸(化合物
(1))3.00g(18.5mmol)をジクロロメ
タン15mlに溶解した溶液に窒素気流下室温で塩化チ
オニル2.70ml(37.0mmol)およびN,N
−ジメチルホルムアミド(DMF)1滴を加え50分間
加熱還流した。反応溶液よりジクロロメタンおよび過剰
の塩化チオニルを留去した後、窒素気流下室温で1,2
−ジクロロエタン50mlおよびN,O−ジメチルヒド
ロキシルアミン塩酸塩2.00g(20.5mmol)
を加え、続いてピリジン3.50ml(43.3mmo
l)を加え1.5時間撹拌した。反応混合物を飽和食塩
水に投じ酢酸エチルで抽出した。抽出層を1N塩酸、飽
和食塩水、炭酸水素ナトリウム水溶液および飽和食塩水
で順次洗浄、硫酸マグネシウム乾燥後濃縮した。濃縮物
をシリカゲルカラムにかけヘキサンと酢酸エチルの1:
1混合溶媒で流し出したところ、(E)−N−メトキシ
−N−メチル−4−フェニル−3−ブテンアミド(化合
物(2))を3.32g、収率87.5%で赤色油状物
として得た。
3.00 g (18.5 mmol) of 4-phenyl-3-butenoic acid (compound (1)) in 15 ml of dichloromethane was dissolved in 2.70 ml (37.0 mmol) of thionyl chloride and N at room temperature under a nitrogen stream. , N
-One drop of dimethylformamide (DMF) was added and the mixture was heated under reflux for 50 minutes. Dichloromethane and excess thionyl chloride were distilled off from the reaction solution, and then 1,2 at room temperature under a nitrogen stream.
-Dichloroethane 50 ml and N, O-dimethylhydroxylamine hydrochloride 2.00 g (20.5 mmol)
Was added, followed by 3.50 ml of pyridine (43.3 mmo
1) was added and stirred for 1.5 hours. The reaction mixture was poured into saturated saline and extracted with ethyl acetate. The extract layer was washed successively with 1N hydrochloric acid, saturated brine, aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column, and hexane and ethyl acetate were mixed with each other at a ratio of 1:
When it was run off with 1 mixed solvent, 3.32 g of (E) -N-methoxy-N-methyl-4-phenyl-3-butenamide (Compound (2)) was obtained in a yield of 87.5% as a red oil. Obtained.

【0024】1HNMR(300MHz,CDCl3 ) δ 3.21(s,3H),3.39(d,J=6.7
Hz,2H),3.73(s,3H),6.37(d
t,J=15.9 and 6.7Hz,1H),6.
52(d,15.9Hz,1H),7.18〜7.42
(m,5H)ppm IR(液膜):2972,2940,1668cm-1 Mass(m/z,%):205(M+ ,32),14
9 (55),144 (35),117 (100),11
5(38),91 (25),69 (24)
1 HNMR (300 MHz, CDCl 3 ) δ 3.21 (s, 3H), 3.39 (d, J = 6.7)
Hz, 2H), 3.73 (s, 3H), 6.37 (d
t, J = 15.9 and 6.7 Hz, 1H), 6.
52 (d, 15.9 Hz, 1H), 7.18 to 7.42
(M, 5H) ppm IR (liquid film): 2972, 2940, 1668 cm -1 Mass (m / z,%): 205 (M + , 32), 14
9 (55), 144 (35), 117 (100), 11
5 (38), 91 (25), 69 (24)

【0025】参考例2 (E)−3,5−ジオキソ−8−フェニル−7−オクテ
ン酸エチル
Reference Example 2 Ethyl (E) -3,5-dioxo-8-phenyl-7-octenoate

【化16】 [Chemical 16]

【0026】水素化ナトリウム(60%)3.21g
(80.3mmol)を無水テトラヒドロフラン(TH
F)80mlに懸濁した溶液にアルゴン気流下0℃でア
セト酢酸エチル10.8ml(84.7mmol)を加
え室温で30分間撹拌した。この溶液を0℃に冷却しブ
チルリチウム(1.66Mヘキサン溶液)52.0ml
を加え室温で20分間撹拌した。溶液を−78℃に冷却
し、参考例1で合成した(E)−N−メトキシ−N−メ
チル−4−フェニル−3−ブテンアミド(化合物
(2))10.9g(52.9mmol)を無水THF
50mlに溶解して10分間かけて加え、1時間撹拌し
た。反応混合物を希塩酸に投じ酢酸エチルで抽出した。
抽出層を飽和食塩水で洗浄、硫酸マグネシウム乾燥後濃
縮した。濃縮物をシリカゲルカラムにかけヘキサンと酢
酸エチルの3:1混合溶媒で流し出したところ(E)−
3,5−ジオキソ−8−フェニル−7−オクテン酸エチ
ル(化合物(3))を9.76g、収率67.3%で無
色油状物として得た。
3.21 g of sodium hydride (60%)
(80.3 mmol) was added to anhydrous tetrahydrofuran (TH
F) To a solution suspended in 80 ml, 10.8 ml (84.7 mmol) of ethyl acetoacetate was added at 0 ° C. under an argon stream, and the mixture was stirred at room temperature for 30 minutes. This solution was cooled to 0 ° C. and 52.0 ml of butyllithium (1.66M hexane solution)
Was added and the mixture was stirred at room temperature for 20 minutes. The solution was cooled to −78 ° C., and 10.9 g (52.9 mmol) of (E) -N-methoxy-N-methyl-4-phenyl-3-butenamide (Compound (2)) synthesized in Reference Example 1 was dried. THF
It was dissolved in 50 ml, added over 10 minutes, and stirred for 1 hour. The reaction mixture was poured into diluted hydrochloric acid and extracted with ethyl acetate.
The extract layer was washed with saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 3: 1 mixed solvent of hexane and ethyl acetate (E)-
Ethyl 3,5-dioxo-8-phenyl-7-octenoate (Compound (3)) was obtained as a colorless oily substance in an amount of 9.76 g in a yield of 67.3%.

【0027】1HNMR(300MHz,CDCl3
ケト:エノール12:88の混合物 δ 1.27(t,J=7.1Hz,3H),3.24
(dd,J=7.1and 1.2Hz,1.76
H),3.34(s,1.76H),3.41〜3.4
6 (m,0.24H),3.56(s,0.24H),
3.81(s,0.24H),4.18(q,J=7.
1Hz,0.24H),4.19(q,J=7.1H
z,1.76H),5.67(s,0.88H),6.
24(dt,J=15.8 and 7.2Hz,0.
88H),6.18〜6.32 (m,0.12H),
6.52(d,J=15.8Hz,1H),7.20〜
7.42(m,5H)ppm IR(液膜):2988,1740,1600cm-1 Mass(m/z,%):274(M+ ,10),18
7 (12),157 (100),144 (26),11
7 (34),115(80),91(13)
1 HNMR (300 MHz, CDCl 3 )
Mixture of keto: enol 12:88 δ 1.27 (t, J = 7.1 Hz, 3H), 3.24.
(Dd, J = 7.1 and 1.2 Hz, 1.76
H), 3.34 (s, 1.76H), 3.41 to 3.4.
6 (m, 0.24H), 3.56 (s, 0.24H),
3.81 (s, 0.24H), 4.18 (q, J = 7.
1Hz, 0.24H), 4.19 (q, J = 7.1H
z, 1.76H), 5.67 (s, 0.88H), 6.
24 (dt, J = 15.8 and 7.2 Hz, 0.
88H), 6.18 to 6.32 (m, 0.12H),
6.52 (d, J = 15.8 Hz, 1H), 7.20-
7.42 (m, 5H) ppm IR (liquid film): 2988, 1740, 1600 cm -1 Mass (m / z,%): 274 (M + , 10), 18
7 (12), 157 (100), 144 (26), 11
7 (34), 115 (80), 91 (13)

【0028】参考例3 (E)−3,5−ジヒドロキシ−8−フェニル−7−オ
クテン酸エチル
Reference Example 3 Ethyl (E) -3,5-dihydroxy-8-phenyl-7-octenoate

【化17】 [Chemical 17]

【0029】参考例2で合成した(E)−3,5−ジオ
キソ−8−フェニル−7−オクテン酸エチル(化合物
(3))9.48g(34.6mmol)を無水THF
50mlおよびメタノール18mlの混合溶媒に加え撹
拌した溶液にアルゴン気流下−78℃でジエチルメトキ
シボラン(1.0M THF溶液)40.0ml(4
0.0mmol)を加えた後、−78℃の冷却バスを外
し室温で30分間撹拌した。この溶液を再び−78℃に
冷却し水素化ホウ素ナトリウム2.67g(70.6m
mol)を3回に分けて加え2時間15分間撹拌した。
反応混合物を0℃で撹拌した30%過酸化水素水400
mlに徐々に加え室温で一晩撹拌した。反応混合物を飽
和食塩水に投じ酢酸エチルで抽出した。抽出層を飽和食
塩水、チオ硫酸ナトリウム水溶液および飽和食塩水で洗
浄、硫酸マグネシウム乾燥後濃縮した。濃縮物をシリカ
ゲルカラムにかけヘキサンと酢酸エチルの1:1混合溶
媒で流し出したところ(E)−3,5−ジヒドロキシ−
8−フェニル−7−オクテン酸エチル(化合物(4))
を7.56g、収率79.2%で得た。
Ethyl (E) -3,5-dioxo-8-phenyl-7-octenoate (Compound (3)) 9.48 g (34.6 mmol) synthesized in Reference Example 2 was added to anhydrous THF.
A mixed solution of 50 ml and 18 ml of methanol was added and stirred to a solution stirred at -78 ° C under an argon stream at 40.0 ml (1.0 M THF solution) of diethyl methoxyborane.
(0.0 mmol) was added, the cooling bath at -78 ° C was removed, and the mixture was stirred at room temperature for 30 minutes. This solution was cooled to -78 ° C again and 2.67 g (70.6 m) of sodium borohydride was added.
(mol) was added in 3 portions and the mixture was stirred for 2 hours and 15 minutes.
The reaction mixture was stirred at 0 ° C. with 30% hydrogen peroxide water 400
The mixture was gradually added to ml and stirred overnight at room temperature. The reaction mixture was poured into saturated saline and extracted with ethyl acetate. The extract layer was washed with saturated brine, aqueous sodium thiosulfate solution and saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 1: 1 mixed solvent of hexane and ethyl acetate (E) -3,5-dihydroxy-
Ethyl 8-phenyl-7-octenoate (Compound (4))
Was obtained with a yield of 79.2%.

【0030】融点:44.0〜45.0℃(無色粒状
晶,酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.27(t,J=7.2Hz,3H),1.56
〜1.72(m,2H),2.41(t with f
ine coupling,J=6.7Hz,2H),
2.38〜2.56 (m,2H),3.34(d,J=
1.9Hz,1H),3.78(d,J=2.4Hz,
1H),3.97〜4.07 (m,1H),4.17
(q,J=7.2Hz,2H),4.24〜4.35
(m,1H),6.23 (dt,J=15.8 and
7.3Hz,1H),6.47(d,J=15.8H
z,1H),7.18〜7.39(m,5H)ppm IR(KBr):3456,2952,1724,15
98cm-1 Mass(FAB−positive,m/z,%):
279(〔M+H〕+,100) Mass(m/z,%):242(M+ −36,37)
,143(59),118(35),117(7
6),115(73),97(100),91(3
3),73(37)
Melting point: 44.0 to 45.0 ° C. (colorless granular crystal, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.27 (t, J = 7.2 Hz, 3 H), 1.56
~ 1.72 (m, 2H), 2.41 (t with f
ine coupling, J = 6.7 Hz, 2H),
2.38 to 2.56 (m, 2H), 3.34 (d, J =
1.9 Hz, 1 H), 3.78 (d, J = 2.4 Hz,
1H), 3.97 to 4.07 (m, 1H), 4.17
(Q, J = 7.2 Hz, 2H), 4.24-4.35.
(m, 1H), 6.23 (dt, J = 15.8 and
7.3 Hz, 1H), 6.47 (d, J = 15.8H
z, 1H), 7.18 to 7.39 (m, 5H) ppm IR (KBr): 3456, 2952, 1724, 15
98 cm -1 Mass (FAB-positive, m / z,%):
279 ([M + H] + , 100) Mass (m / z,%): 242 (M + -36, 37)
, 143 (59), 118 (35), 117 (7)
6), 115 (73), 97 (100), 91 (3
3), 73 (37)

【0031】参考例4 (E)−8−フェニル−3,5−O−イソプロピリデン
−3,5−ジヒドロキシ−7−オクテン酸エチル
Reference Example 4 Ethyl (E) -8-phenyl-3,5-O-isopropylidene-3,5-dihydroxy-7-octenoate

【化18】 [Chemical 18]

【0032】参考例3で合成した(E)−3,5−ジヒ
ドロキシ−8−フェニル−7−オクテン酸エチル(化合
物(4))2.00g(7.19mmol)を2,2−
ジメトキシプロパン7.0mlに溶解しアルゴン気流下
室温で撹拌した溶液にp−トルエンスルホン酸一水和物
18mg(0.09mmol)を加え2時間撹拌した。
反応混合物を炭酸水素ナトリウム水溶液に投じ酢酸エチ
ルで抽出した。抽出層を飽和食塩水で洗浄、硫酸マグネ
シウム乾燥後濃縮した。濃縮物をシリカゲルカラムにか
けヘキサンと酢酸エチルの3:1混合溶媒で流し出した
ところ(E)−8−フェニル−3,5−O−イソプロピ
リデン−3,5−ジヒドロキシ−7−オクテン酸エチル
(化合物(5))を2.18g、収率95.4%で無色
油状物として得た。
2.00 g (7.19 mmol) of ethyl (E) -3,5-dihydroxy-8-phenyl-7-octenoate (Compound (4)) synthesized in Reference Example 3 was added to 2,2-.
18 mg (0.09 mmol) of p-toluenesulfonic acid monohydrate was added to a solution which was dissolved in 7.0 ml of dimethoxypropane and stirred at room temperature under an argon stream, and stirred for 2 hours.
The reaction mixture was poured into an aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The extract layer was washed with saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 3: 1 mixed solvent of hexane and ethyl acetate to give (E) -8-phenyl-3,5-O-isopropylidene-3,5-dihydroxy-7-octenoate ( 2.18 g of compound (5)) was obtained as a colorless oily substance in a yield of 95.4%.

【0033】1HNMR(300MHz,CDCl3 ) δ 1.25 (t,J=7.1Hz,3H),1.17
〜1.31 (m,1H),1.40(s,3H),1.
47(s,3H),1.64(dt,J=12.8 a
nd 2.5Hz,1H),2.25〜2.53 (m,
2H),2.37 (dd,J=15.4 and 6.
1Hz,1H),2.53 (dd,J=15.4 an
d 7.0Hz,1H),3.98(dtd,J=1
1.4,6.2 and 2.5Hz,1H),4.0
6〜4.22 (m,2H),4.26〜4.37 (m,
1H),6.20 (dt,J=15.9 and 7.
1Hz,1H),6.44(d,J=15.9Hz,1
H),7.16〜7.40 (m,5H)ppm IR(液膜):2992,2944,1740,160
0cm-1 Mass(FAB−positive,m/z,%):
319(〔M+H〕+,6) Mass(m/z,%):303(M+ −15,2
6),201(75),183(34),155(3
9),143(100),129(38),115(4
9),97(56)
1 HNMR (300 MHz, CDCl 3 ) δ 1.25 (t, J = 7.1 Hz, 3 H), 1.17
~ 1.31 (m, 1H), 1.40 (s, 3H), 1.
47 (s, 3H), 1.64 (dt, J = 12.8 a
nd 2.5Hz, 1H), 2.25 to 2.53 (m,
2H), 2.37 (dd, J = 15.4 and 6.
1Hz, 1H), 2.53 (dd, J = 15.4 an
d 7.0 Hz, 1H), 3.98 (dtd, J = 1)
1.4, 6.2 and 2.5Hz, 1H), 4.0
6 to 4.22 (m, 2H), 4.26 to 4.37 (m,
1H), 6.20 (dt, J = 15.9 and 7.
1Hz, 1H), 6.44 (d, J = 15.9Hz, 1
H), 7.16 to 7.40 (m, 5H) ppm IR (liquid film): 2992, 2944, 1740, 160
0 cm -1 Mass (FAB-positive, m / z,%):
319 ([M + H] + , 6) Mass (m / z,%): 303 (M + -15, 2 )
6), 201 (75), 183 (34), 155 (3
9), 143 (100), 129 (38), 115 (4
9), 97 (56)

【0034】参考例5 7−オキソ−3,5−O−イソプロピリデン−3,5−
ジヒドロキシヘプタン酸エチル
Reference Example 5 7-oxo-3,5-O-isopropylidene-3,5-
Ethyl dihydroxyheptanoate

【化19】 [Chemical 19]

【0035】参考例4で合成した(E)−8−フェニル
−3,5−O−イソプロピリデン−3,5−ジヒドロキ
シ−7−オクテン酸エチル(化合物(5))1.50g
(4.72mmol)をジクロロメタン100mlに加
え−78℃で撹拌した溶液に1時間オゾンを通した。反
応混合物より過剰のオゾンを青色の溶液の色が無色にな
るまでアルゴンでパージすることによって除いた後、ト
リフェニルホスフィン1.50g(5.72mmol)
を加え30分間撹拌後室温で1時間撹拌した。反応混合
物を濃縮しシリカゲルカラムにかけヘキサンと酢酸エチ
ルの2:1混合溶媒で流し出したところ7−オキソ−
3,5−O−イソプロピリデン−3,5−ジヒドロキシ
ヘプタン酸エチル(化合物(6))を1.10g、収率
95.4%で無色油状物として得た。
1.50 g of ethyl (E) -8-phenyl-3,5-O-isopropylidene-3,5-dihydroxy-7-octenoate (compound (5)) synthesized in Reference Example 4
(4.72 mmol) was added to 100 ml of dichloromethane, and ozone was passed through the solution stirred at -78 ° C for 1 hour. Excess ozone from the reaction mixture was removed by purging with argon until the color of the blue solution became colorless, then 1.50 g (5.72 mmol) triphenylphosphine.
Was added, and the mixture was stirred for 30 minutes and then stirred at room temperature for 1 hour. The reaction mixture was concentrated, applied to a silica gel column and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate.
Ethyl 3,5-O-isopropylidene-3,5-dihydroxyheptanoate (Compound (6)) was obtained as a colorless oily substance in an amount of 1.10 g and a yield of 95.4%.

【0036】1HNMR(300MHz,CDCl3 ) δ 1.27(t,J=7.1Hz,3H),1.22
〜1.35 (m,1H),1.37(s,3H),1.
50(s,3H),1.69(dt,J=12.7 a
nd 2.5Hz,1H),2.39(dd,J=1
5.5 and6.1Hz,1H),2.49(dd
d,J=16.6,5.0 and 1.6Hz,1
H),2.55(dd,J=15.5 and 7.1
Hz,1H),2.63(ddd,J=16.6,7.
3 and 2.3Hz,1H),4.08〜4.25
(m,2H),4.32〜4.51 (m,2H),9.
79 (dd,J=2.3 and 1.6Hz,1H)
ppm IR(液膜):2996,1734cm-1 Mass(FAB−positive,m/z,%):
245(〔M+H〕+,82) Mass(m/z,%):229(M+ −15,10
0) ,201(19)
1 HNMR (300 MHz, CDCl 3 ) δ 1.27 (t, J = 7.1 Hz, 3 H), 1.22
˜1.35 (m, 1H), 1.37 (s, 3H), 1.
50 (s, 3H), 1.69 (dt, J = 12.7 a
nd 2.5Hz, 1H), 2.39 (dd, J = 1)
5.5 and 6.1 Hz, 1H), 2.49 (dd
d, J = 16.6, 5.0 and 1.6 Hz, 1
H), 2.55 (dd, J = 15.5 and 7.1)
Hz, 1H), 2.63 (ddd, J = 16.6, 7.
3 and 2.3 Hz, 1H), 4.08 to 4.25.
(m, 2H), 4.32-4.51 (m, 2H), 9.
79 (dd, J = 2.3 and 1.6Hz, 1H)
ppm IR (liquid film): 2996, 1734 cm -1 Mass (FAB-positive, m / z,%):
245 ([M + H] + , 82) Mass (m / z,%): 229 (M + -15, 10)
0), 201 (19)

【0037】参考例6 1−(4−フルオロフェニル)−4−メチル−1−ペン
テン−3−オン
Reference Example 6 1- (4-Fluorophenyl) -4-methyl-1-penten-3-one

【化20】 [Chemical 20]

【0038】3−メチル−2−ブタノン(化合物
(8))50.0ml(466mmol)をエタノール
130mlと水100ml及び2N水酸化ナトリウム水
溶液7.78ml(15.5mmol)の混合溶液に加
え、続いて0℃で4−フルオロベンズアルデヒド(化合
物(7))33.3ml(311mmol)を加え、ア
ルゴン雰囲気下室温にて一晩撹拌した。反応液を希塩酸
に投じ、酢酸エチルで抽出、抽出層を、水、飽和食塩水
で洗浄、硫酸マグネシウム乾燥後濃縮したところ1−
(4−フルオロフェニル)−4−メチル−1−ペンテン
−3−オン(化合物(9))の粗精製物を50.4g、
収率90.1%で淡黄色油状物として得た。
50.0 ml (466 mmol) of 3-methyl-2-butanone (compound (8)) was added to a mixed solution of 130 ml of ethanol, 100 ml of water and 7.78 ml (15.5 mmol) of 2N sodium hydroxide aqueous solution, and subsequently. 4-Fluorobenzaldehyde (Compound (7)) 33.3 ml (311 mmol) was added at 0 ° C., and the mixture was stirred overnight at room temperature under an argon atmosphere. The reaction solution was poured into diluted hydrochloric acid and extracted with ethyl acetate. The extract layer was washed with water and saturated saline, dried over magnesium sulfate, and then concentrated.
50.4 g of a crude product of (4-fluorophenyl) -4-methyl-1-penten-3-one (compound (9)),
Obtained as a pale yellow oil in a yield of 90.1%.

【0039】1HNMR(300MHz,CDCl3 ) δ 1.18(d,J=6.9Hz,6H),2.92
(hept,J=6.9Hz,1H),7.75(d
with fine coupling,J=16.0
Hz,1H),7.04〜7.13(m,2H),7.
51〜7.62(m,3H)ppm IR(液膜):2976,2936,1692,166
6,1616,1600cm-1 Mass(m/z,%):192(M+ ,13),14
9(100),121(21),101(16)
1 HNMR (300 MHz, CDCl 3 ) δ 1.18 (d, J = 6.9 Hz, 6H), 2.92
(Hept, J = 6.9 Hz, 1H), 7.75 (d
with fine coupling, J = 16.0
Hz, 1H), 7.04 to 7.13 (m, 2H), 7.
51-7.62 (m, 3H) ppm IR (liquid film): 2976, 2936, 1692, 166
6,1616,1600 cm -1 Mass (m / z,%): 192 (M + , 13), 14
9 (100), 121 (21), 101 (16)

【0040】参考例7 6−アセチル−5−(4−フルオロフェニル)−3−
(プロパン−2−イル)−2−シクロヘキセン−1−オ
Reference Example 7 6-Acetyl-5- (4-fluorophenyl) -3-
(Propan-2-yl) -2-cyclohexen-1-one

【化21】 [Chemical 21]

【0041】2,4−ペンタンジオン(化合物(1
0))4.11ml(40.0mmol)をトルエン2
0mlに加え、DBU0.60ml(4.0mmol)
を加えて攪拌した溶液に参考例6で合成した1−(4−
フルオロフェニル)−4−メチル−1−ペンテン−3−
オン(化合物(9))3.84g(20.0mmol)
を加え、アルゴン雰囲気下室温にて二日間攪拌した。反
応液を1N塩酸に投じ、酢酸エチルで抽出、抽出層を、
水、飽和食塩水で洗浄、硫酸マグネシウム乾燥後濃縮
し、酢酸エチルとヘキサンより結晶化した。ろ液を濃縮
しシリカゲルカラムにかけ酢酸エチルとヘキサンの混合
溶媒で流し出した後、酢酸エチルとヘキサンより結晶化
し合計4.31gの結晶を得た。得られた結晶のうち
3.98gをトルエン25mlに溶かし、リン酸(85
%)2mlを加え、アルゴン雰囲気下3時間加熱還流し
た。反応液を飽和炭酸水素ナトリウム水溶液に投じ酢酸
エチルで抽出、抽出層を飽和炭酸水素ナトリウム水溶
液、水、飽和食塩水で順次洗浄、硫酸マグネシウム乾燥
後濃縮した。濃縮物をシリカゲルカラムにかけ酢酸エチ
ルとヘキサンの1:4混合溶媒で流し出したところ6−
アセチル−5−(4−フルオロフェニル)−3−(プロ
パン−2−イル)−2−シクロヘキセン−1−オン(化
合物(11))を淡黄色油状物として2.44g得た。
2,4-Pentanedione (Compound (1
0)) 4.11 ml (40.0 mmol) of toluene 2
In addition to 0 ml, DBU 0.60 ml (4.0 mmol)
1- (4-synthesized in Reference Example 6)
Fluorophenyl) -4-methyl-1-pentene-3-
On (compound (9)) 3.84 g (20.0 mmol)
Was added and the mixture was stirred at room temperature for 2 days under an argon atmosphere. The reaction solution was poured into 1N hydrochloric acid and extracted with ethyl acetate.
The extract was washed with water and saturated brine, dried over magnesium sulfate, concentrated, and crystallized from ethyl acetate and hexane. The filtrate was concentrated, applied to a silica gel column, poured out with a mixed solvent of ethyl acetate and hexane, and crystallized from ethyl acetate and hexane to obtain 4.31 g of crystals in total. 3.98 g of the obtained crystals was dissolved in 25 ml of toluene, and phosphoric acid (85
%) 2 ml, and the mixture was heated under reflux for 3 hours under an argon atmosphere. The reaction mixture was poured into saturated aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The extract layer was washed successively with saturated aqueous sodium hydrogen carbonate solution, water and saturated brine, dried over magnesium sulfate and concentrated. When the concentrate was applied to a silica gel column and poured out with a 1: 4 mixed solvent of ethyl acetate and hexane, 6-
2.44 g of acetyl-5- (4-fluorophenyl) -3- (propan-2-yl) -2-cyclohexen-1-one (Compound (11)) was obtained as a pale yellow oil.

【0042】1HNMR(300MHz,CDCl3
ケト:エノール1:9の混合物 δ 0.84(d,J=6.8Hz,2.7H),0.
87(d,J=6.8Hz,2.7H),1.12
(d,J=6.8Hz,0.6H),1.93(s,
2.7H),2.10(S,0.3H),2.22(h
ept,J=6.8Hz,0.9H),2.38(d
d,J=17.0 and 1.7Hz,0.9H),
2.41〜2.51(m,0.1H),2.51(dd
d,J=18.0,10.0 and 2.0Hz,
0.1H),2.61(dd,J=18.0and
5.1Hz,0.1H),2.88(ddd,J=1
7.0,8.0and 2.7Hz,0.9H),3.
66(ddd,J=12.1,10.0 and 5.
1Hz,0.1H),3.77(d,J=12.1H
z,0.1H),3.97(d with fine
coupling,J=8.0Hz,0.9Hz),
5.94(dd,J=2.7 and 1.0Hz,
0.9H),5.99(s with fine co
upling,0.1H),6.90〜7.05(m,
2H),7.09〜7.24(m,2H)ppm IR(液膜):2936,1722,1660,163
0,1606cm-1 Mass(m/z,%):274(M+ ,55),23
1(100),189(38),43(34)
1 HNMR (300 MHz, CDCl 3 )
Mixture of keto: enol 1: 9 δ 0.84 (d, J = 6.8 Hz, 2.7H), 0.
87 (d, J = 6.8 Hz, 2.7 H), 1.12
(D, J = 6.8 Hz, 0.6 H), 1.93 (s,
2.7H), 2.10 (S, 0.3H), 2.22 (h
ept, J = 6.8 Hz, 0.9 H), 2.38 (d
d, J = 17.0 and 1.7 Hz, 0.9 H),
2.41 to 2.51 (m, 0.1H), 2.51 (dd
d, J = 18.0, 10.0 and 2.0 Hz,
0.1H), 2.61 (dd, J = 18.0 and
5.1Hz, 0.1H), 2.88 (ddd, J = 1)
7.0, 8.0 and 2.7 Hz, 0.9 H), 3.
66 (ddd, J = 12.1, 10.0 and 5.
1Hz, 0.1H), 3.77 (d, J = 12.1H)
z, 0.1H), 3.97 (d with fine)
coupling, J = 8.0 Hz, 0.9 Hz),
5.94 (dd, J = 2.7 and 1.0 Hz,
0.9H), 5.99 (s with fine co
upling, 0.1H), 6.90 to 7.05 (m,
2H), 7.09 to 7.24 (m, 2H) ppm IR (liquid film): 2936, 1722, 1660, 163.
0.1606 cm -1 Mass (m / z,%): 274 (M + , 55), 23
1 (100), 189 (38), 43 (34)

【0043】参考例8 6−(4−フルオロフェニル)−2−ヒドロキシ−4−
(プロパン−2−イル)アセトフェノン
Reference Example 8 6- (4-Fluorophenyl) -2-hydroxy-4-
(Propan-2-yl) acetophenone

【化22】 [Chemical formula 22]

【0044】参考例7で合成した6−アセチル−5−
(4−フルオロフェニル)−3−(プロパン−2−イ
ル)−2−シクロヘキセン−1−オン(化合物(1
1))1.78g(6.50mmol)をジエチレング
リコールジメチルエーテル15mlに溶かし、イソホロ
ン0.97ml(6.50mmol)続いて10%Pd
−C356mgを加え、窒素ガスをバブリングしながら
30分間加熱還流した。反応混合物を酢酸エチルで希釈
しセライトろ過し濃縮した後蒸留によりジエチレングリ
コールジメチルエーテルを除いた後シリカゲルカラムに
かけ酢酸エチルとヘキサンの1:10混合溶媒で流し出
したところ6−(4−フルオロフェニル)−2−ヒドロ
キシ−4−(プロパン−2−イル)アセトフェノン(化
合物(12))を1.25g、収率70.7%で得た。
6-Acetyl-5-synthesized in Reference Example 7
(4-Fluorophenyl) -3- (propan-2-yl) -2-cyclohexen-1-one (Compound (1
1)) 1.78 g (6.50 mmol) was dissolved in 15 ml of diethylene glycol dimethyl ether, and 0.97 ml (6.50 mmol) of isophorone followed by 10% Pd.
-C356 mg was added, and the mixture was heated under reflux for 30 minutes while bubbling nitrogen gas. The reaction mixture was diluted with ethyl acetate, filtered through Celite, concentrated, and after removing diethylene glycol dimethyl ether by distillation, the mixture was applied to a silica gel column and was poured out with a 1:10 mixed solvent of ethyl acetate and hexane. 6- (4-fluorophenyl) -2 1.25 g of -hydroxy-4- (propan-2-yl) acetophenone (compound (12)) was obtained with a yield of 70.7%.

【0045】融点:52.5〜53.5℃(無色柱状
晶、ヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.26(d,J=6.9Hz,6H),1.84
(s,3H),2.89(hept,J=6.9Hz,
1H),6.65(d,J=1.7Hz,1H),6.
87(d,J=1.7Hz,1H),7.09〜7.1
8(m,2H),7.27〜7.36(m,2H),1
1.91(s,1H)ppm IR(KBr):2964,2876,1630,16
08cm-1 Mass(m/z,%):272(M+ ,82),25
7(100),229(26),215(36),18
3(13),149(18),43(16)
Melting point: 52.5-53.5 ° C. (colorless columnar crystal, recrystallized from hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.26 (d, J = 6.9 Hz, 6 H), 1.84
(S, 3H), 2.89 (hept, J = 6.9 Hz,
1H), 6.65 (d, J = 1.7Hz, 1H), 6.
87 (d, J = 1.7 Hz, 1H), 7.09 to 7.1
8 (m, 2H), 7.27 to 7.36 (m, 2H), 1
1.91 (s, 1H) ppm IR (KBr): 2964, 2876, 1630, 16
08 cm -1 Mass (m / z,%): 272 (M + , 82), 25
7 (100), 229 (26), 215 (36), 18
3 (13), 149 (18), 43 (16)

【0046】参考例9 4′−フルオロ−5−(プロパン−2−イル)ビフェニ
ル−2,3−ジオール
Reference Example 9 4'-Fluoro-5- (propan-2-yl) biphenyl-2,3-diol

【化23】 [Chemical formula 23]

【0047】参考例8で合成した6−(4−フルオロフ
ェニル)−2−ヒドロキシ−4−(プロパン−2−イ
ル)アセトフェノン(化合物(12))973mg
(3.58mmol)をTHF5mlに溶かし、0℃に
て1N水酸化ナトリウム10.7ml(10.7mmo
l)、続いて30%過酸化水素水2.03ml(17.
9mmol)を加え、アルゴン雰囲気下2時間45分間
攪拌した。反応液を飽和塩化アンモニウム水溶液に投
じ、酢酸エチルで抽出、水層を1N塩酸でpH2として
再び酢酸エチルで抽出したのち抽出層をあわせた。抽出
層を水、飽和チオ硫酸ナトリウム水溶液、水、飽和食塩
水で順次洗浄、硫酸マグネシウム乾燥後濃縮した。濃縮
物を酢酸エチルとヘキサンより結晶化したところ4′−
フルオロ−5−(プロパン−2−イル)ビフェニル−
2,3−ジオール(化合物(13))を523mg、収
率59.4%で得た。ろ液を濃縮しシリカゲルカラムに
かけ酢酸エチルとヘキサンの1:3混合溶媒で流し出し
たところさらに化合物(13)を227mg、収率2
5.8%で得た。
973 mg of 6- (4-fluorophenyl) -2-hydroxy-4- (propan-2-yl) acetophenone (compound (12)) synthesized in Reference Example 8
(3.58 mmol) was dissolved in 5 ml of THF, and 1N sodium hydroxide (10.7 ml, 10.7 mmo) was added at 0 ° C.
l), followed by 2.03 ml of 30% hydrogen peroxide solution (17.
9 mmol) was added, and the mixture was stirred under an argon atmosphere for 2 hours and 45 minutes. The reaction solution was poured into a saturated ammonium chloride aqueous solution and extracted with ethyl acetate. The aqueous layer was adjusted to pH 2 with 1N hydrochloric acid and extracted again with ethyl acetate, and then the extracted layers were combined. The extract layer was washed successively with water, saturated aqueous sodium thiosulfate solution, water and saturated brine, dried over magnesium sulfate and concentrated. Crystallization of the concentrate from ethyl acetate and hexane gave 4'-
Fluoro-5- (propan-2-yl) biphenyl-
523 mg of 2,3-diol (compound (13)) was obtained with a yield of 59.4%. The filtrate was concentrated, applied to a silica gel column and poured out with a 1: 3 mixed solvent of ethyl acetate and hexane, and further 227 mg of compound (13) was obtained in a yield of 2
Obtained at 5.8%.

【0048】融点:106.0〜107.0℃(無色柱
状晶、酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.23(d,J=6.9Hz,6H),2.83
(hept,J=6.9Hz,1H),5.04(br
oad s,1H),5.31(broads,1
H),6.66(d,J=2.1H.,1H),6.8
0(d,J=2.1Hz,1H),7.12〜7.21
(m,2H),7.44〜7.53(m,2H)ppm IR(KBr):3496,3368,2964,28
72,1606cm-1Mass(m/z,%):246
(M+ ,57),231(100),149(23),
57(10)
Melting point: 106.0 to 107.0 ° C. (colorless columnar crystal, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.23 (d, J = 6.9 Hz, 6 H), 2.83
(Hept, J = 6.9 Hz, 1H), 5.04 (br
oads, 1H), 5.31 (broads, 1
H), 6.66 (d, J = 2.1H., 1H), 6.8.
0 (d, J = 2.1 Hz, 1H), 7.12-7.21
(M, 2H), 7.44 to 7.53 (m, 2H) ppm IR (KBr): 3496, 3368, 2964, 28
72,1606 cm -1 Mass (m / z,%): 246
(M + , 57), 231 (100), 149 (23),
57 (10)

【0049】参考例10 4′−フルオロ−2,3−ジメトキシ−5−(プロパン
−2−イル)ビフェニル
Reference Example 10 4'-Fluoro-2,3-dimethoxy-5- (propan-2-yl) biphenyl

【化24】 [Chemical formula 24]

【0050】参考例9で合成した4′−フルオロ−5−
(プロパン−2−イル)ビフェニル−2,3−ジオール
(化合物(13))695mg(2.83mmol)を
DMF7mlに溶かし、ヨウ化メチル0.71ml(1
1.3mmol)、続いて炭酸カリウム1.56g(1
1.3mmol)を加え、アルゴン雰囲気下3時間攪拌
した。反応液を水に投じ、酢酸エチルで抽出、抽出層を
飽和食塩水で洗浄、硫酸マグネシウム乾燥後濃縮した。
濃縮物をシリカゲルカラムにかけ酢酸エチルとヘキサン
の1:6混合溶媒で流し出したところ4′−フルオロ−
2,3−ジメトキシ−5−(プロパン−2−イル)ビフ
ェニル(化合物(14))を746mg、収率96.2
%で得た。
4'-Fluoro-5-synthesized in Reference Example 9
(Propan-2-yl) biphenyl-2,3-diol (Compound (13)) 695 mg (2.83 mmol) was dissolved in DMF 7 ml, and methyl iodide 0.71 ml (1
1.3 mmol), followed by 1.56 g (1
1.3 mmol) was added, and the mixture was stirred under an argon atmosphere for 3 hours. The reaction solution was poured into water and extracted with ethyl acetate. The extract layer was washed with saturated brine, dried over magnesium sulfate and concentrated.
The concentrate was applied to a silica gel column and poured out with a 1: 6 mixed solvent of ethyl acetate and hexane to give 4'-fluoro-
746 mg of 2,3-dimethoxy-5- (propan-2-yl) biphenyl (compound (14)), yield 96.2
Earned in%.

【0051】融点:59.0〜60.0℃(無色微粒状
晶、ヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.27(d,J=6.9Hz,6H),2.90
(hept,J=6.9Hz,1H),3.55(s,
3H),3.91(s,3H),6.76(d,J=
2.1Hz,1H),6.77(d,J=2.1Hz,
1H),7.06〜7.15(m,2H),7.49〜
7.57(m,2H)ppm IR(KBr):2964,2880,1600,15
80cm-1 Mass(m/z,%):274(M+ ,98),25
9(100),217(20),202(14),14
9(34),57(17)
Melting point: 59.0 to 60.0 ° C. (colorless fine granular crystal, recrystallized from hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.27 (d, J = 6.9 Hz, 6 H), 2. 90
(Hept, J = 6.9 Hz, 1H), 3.55 (s,
3H), 3.91 (s, 3H), 6.76 (d, J =
2.1 Hz, 1 H), 6.77 (d, J = 2.1 Hz,
1H), 7.06 to 7.15 (m, 2H), 7.49 to
7.57 (m, 2H) ppm IR (KBr): 2964, 2880, 1600, 15
80 cm -1 Mass (m / z,%): 274 (M + , 98), 25
9 (100), 217 (20), 202 (14), 14
9 (34), 57 (17)

【0052】参考例11 2−ブロモ−4′−フルオロ−5,6−ジメトキシ−3
−(プロパン−2−イル)ビフェニル
Reference Example 11 2-Bromo-4'-fluoro-5,6-dimethoxy-3
-(Propan-2-yl) biphenyl

【化25】 [Chemical 25]

【0053】参考例10で合成した4′−フルオロ−
2,3−ジメトキシ−5−(プロパン−2−イル)ビフ
ェニル(化合物(14))30.1g(110mmo
l)をTHF300mlと水30mlの混合溶媒に溶か
し、0℃にてN−ブロモこはく酸イミド20.5g(1
15mmol)を加え、アルゴン雰囲気下室温で2時間
45分間攪拌した。反応液を水に投じ、酢酸エチルで抽
出、抽出層を飽和チオ硫酸ナトリウム水溶液、水、飽和
食塩水で順次洗浄、硫酸マグネシウム乾燥後濃縮した。
濃縮物を酢酸エチルとヘキサンより結晶化したところ2
−ブロモ−4′−フルオロ−5,6−ジメトキシ−3−
(プロパン−2−イル)ビフェニル(化合物(15))
を37.0g、収率95.7%で得た。ろ液を濃縮しシ
リカゲルカラムにかけジクロロメタンとヘキサンの1:
1混合溶媒で流し出したところ化合物(15)を1.1
5g、収率3.0%で得た。
4'-Fluoro-synthesized in Reference Example 10
2,3-Dimethoxy-5- (propan-2-yl) biphenyl (Compound (14)) 30.1 g (110 mmo)
l) was dissolved in a mixed solvent of 300 ml of THF and 30 ml of water, and 20.5 g of N-bromosuccinimide (1
15 mmol) was added, and the mixture was stirred at room temperature for 2 hours and 45 minutes under an argon atmosphere. The reaction mixture was poured into water and extracted with ethyl acetate. The extract layer was washed successively with saturated aqueous sodium thiosulfate solution, water and saturated brine, dried over magnesium sulfate and concentrated.
When the concentrate was crystallized from ethyl acetate and hexane, 2
-Bromo-4'-fluoro-5,6-dimethoxy-3-
(Propan-2-yl) biphenyl (Compound (15))
Was obtained with a yield of 95.7%. The filtrate is concentrated, applied to a silica gel column, and the mixture of dichloromethane and hexane is 1: 1:
When the compound (15) was eluted with 1 mixed solvent, 1.1
5 g, yield 3.0%.

【0054】融点:127.0〜127.5℃(無色微
粒状晶、ヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.27(d,J=6.8Hz,6H),3.45
(hept,J=6.8Hz,1H),3.50(s,
3H),3.91(s,3H),6.89(s,1
H),7.08〜7.16(m,2H),7.20〜
7.29(m,2H)ppm IR(KBr):2972,2936,1604,15
80cm-1 Mass(m/z,%):354(M+ ,99),35
2(M+ ,100),339(81),337(8
2),324(23),322(24),243(2
8),149(26),69(17)
Melting point: 127.0 to 127.5 ° C. (colorless fine granular crystal, recrystallized from hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.27 (d, J = 6.8 Hz, 6 H), 3. 45
(Hept, J = 6.8 Hz, 1H), 3.50 (s,
3H), 3.91 (s, 3H), 6.89 (s, 1
H), 7.08 to 7.16 (m, 2H), 7.20 to
7.29 (m, 2H) ppm IR (KBr): 2972, 2936, 1604, 15
80 cm -1 Mass (m / z,%): 354 (M + , 99), 35
2 (M + , 100), 339 (81), 337 (8
2), 324 (23), 322 (24), 243 (2
8), 149 (26), 69 (17)

【0055】実施例1 7−〔4′−フルオロ−5,6−ジメトキシ−3−(プ
ロパン−2−イル)ビフェニル−2−イル〕−3,5−
O−イソプロピリデン−3,5,7−トリヒドロキシヘ
プタン酸エチル
Example 1 7- [4'-Fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-
Ethyl O-isopropylidene-3,5,7-trihydroxyheptanoate

【化26】 [Chemical formula 26]

【0056】参考例11で合成した2−ブロモ−4′−
フルオロ−5,6−ジメトキシ−3−(プロパン−2−
イル)ビフェニル(化合物(15))750mg(2.
11mmol)およびマグネシウム(削り状)207m
g(8.52mmol)を無水THF4mlに加えアル
ゴン雰囲気下加熱還流した溶液に、1,2−ジブロモエ
タン0.27ml(2.10mmol)を無水THF4
mlに溶解して10分間かけて加え、1時間加熱還流し
た。この溶液に参考例5で合成した7−オキソ−3,5
−O−イソプロピリデン−3,5−ジヒドロキシヘプタ
ン酸エチル(6)620mg(2.54mmol)を無
水THF2mlに溶解して加え、続いて室温で1時間撹
拌した。反応混合物を飽和塩化アンモニウム水溶液に投
じ酢酸エチルで抽出した。抽出層を飽和食塩水で洗浄、
硫酸マグネシウム乾燥後濃縮した。濃縮物をシリカゲル
カラムにかけヘキサンと酢酸エチルの2:1混合溶媒で
流し出したところ、7−〔4′−フルオロ−5,6−ジ
メトキシ−3−(プロパン−2−イル)ビフェニル−2
−イル〕−3,5−O−イソプロピリデン−3,5,7
−トリヒドロキシヘプタン酸エチル(化合物(16))
を694mg、63.3%の収率で無色不定形固体とし
て得た。
2-Bromo-4'-synthesized in Reference Example 11
Fluoro-5,6-dimethoxy-3- (propane-2-
Yl) biphenyl (compound (15)) 750 mg (2.
11 mmol) and magnesium (shavings) 207 m
g (8.52 mmol) was added to anhydrous THF (4 ml) and heated under reflux under an argon atmosphere to obtain a solution, and 1,2-dibromoethane (0.27 ml, 2.10 mmol) was added to anhydrous THF (4).
It was dissolved in ml, added over 10 minutes, and heated under reflux for 1 hour. 7-oxo-3,5 synthesized in Reference Example 5 was added to this solution.
620 mg (2.54 mmol) of ethyl -O-isopropylidene-3,5-dihydroxyheptanoate (6) was dissolved in 2 ml of anhydrous THF and added, followed by stirring at room temperature for 1 hour. The reaction mixture was poured into saturated aqueous ammonium chloride solution and extracted with ethyl acetate. Wash the extract layer with saturated saline,
The extract was dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate to give 7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2.
-Yl] -3,5-O-isopropylidene-3,5,7
-Ethyl trihydroxyheptanoate (compound (16))
Was obtained as a colorless amorphous solid in a yield of 694 mg, 63.3%.

【0057】1:1の立体異性体の混合物1 HNMR(300MHz,CDCl3 ) δ 0.97(dd,J=24.3 and 11.8
Hz,0.5H),1.10(dd,J=24.3 a
nd 11.8Hz,0.5H),1.22〜1.31
(m,15H),1.37〜1.44 (m,0.5
H),1.48〜1.60 (m,0.5H),2.04
〜2.54 (m,4H),2.87 (broad s,
0.5H),3.46(s,1.5H),3.47
(s,1.5H),3.75〜3.92 (m,1H),
3.89(s,3H),3.98〜4.28 (m,4
H),4.68〜4.75(m,0.5H),4.87
〜4.94 (m,0.5H),6.91 (s,1H),
7.00〜7.30 (m,4H)ppm IR(KBr):3532,2992,2956,17
38,1590cm-1 Mass(m/z,%):518(M+ ,20),44
2 (100),424(85),327 (91),28
5 (77),283 (81),183 (20),43
(37)
1: 1 mixture of stereoisomers 1 HNMR (300 MHz, CDCl 3 ) δ 0.97 (dd, J = 24.3 and 11.8)
Hz, 0.5H), 1.10 (dd, J = 24.3a)
nd 11.8Hz, 0.5H), 1.22 to 1.31
(m, 15H), 1.37 to 1.44 (m, 0.5
H), 1.48 to 1.60 (m, 0.5H), 2.04
~ 2.54 (m, 4H), 2.87 (broads,
0.5H), 3.46 (s, 1.5H), 3.47
(S, 1.5H), 3.75 to 3.92 (m, 1H),
3.89 (s, 3H), 3.98 to 4.28 (m, 4
H), 4.68 to 4.75 (m, 0.5H), 4.87.
~ 4.94 (m, 0.5H), 6.91 (s, 1H),
7.00-7.30 (m, 4H) ppm IR (KBr): 3532, 2992, 2956, 17
38,1590 cm -1 Mass (m / z,%): 518 (M + , 20), 44
2 (100), 424 (85), 327 (91), 28
5 (77), 283 (81), 183 (20), 43
(37)

【0058】実施例2 (E)−7−〔4′−フルオロ−5,6−ジメトキシ−
3−(プロパン−2−イル)ビフェニル−2−イル〕−
3,5−O−イソプロピリデン−3,5−ジヒドロキシ
−6−ヘプテン酸エチル
Example 2 (E) -7- [4'-fluoro-5,6-dimethoxy-
3- (propan-2-yl) biphenyl-2-yl]-
Ethyl 3,5-O-isopropylidene-3,5-dihydroxy-6-heptenoate

【化27】 [Chemical 27]

【0059】実施例1で合成した7−〔4′−フルオロ
−5,6−ジメトキシ−3−(プロパン−2−イル)ビ
フェニル−2−イル〕−3,5−O−イソプロピリデン
−3,5,7−トリヒドロキシヘプタン酸エチル(化合
物(16))225mg(0.43mmol)を1,2
−ジクロロエタン4mlに溶解し、0℃にて無水ピリジ
ン0.11ml(1.30mmol)、続いて塩化チオ
ニル0.04ml(0.49mmol)を加えアルゴン
雰囲気下50分間撹拌した。反応液を水に投じ酢酸エチ
ルで抽出、抽出層を、炭酸水素ナトリウム水溶液、飽和
食塩水で洗浄、硫酸マグネシウム乾燥後濃縮した。濃縮
物を1,2−ジクロロエタン5mlに溶解し、無水ピリ
ジン0.10ml(1.24mmol)を加えアルゴン
雰囲気下5時間加熱還流した。反応液を水に投じ酢酸エ
チルで抽出、抽出層を飽和食塩水、飽和炭酸水素ナトリ
ウム水溶液、飽和食塩水で順次洗浄、硫酸マグネシウム
乾燥後濃縮した。濃縮物を酢酸エチルとヘキサンより結
晶化したところ(E)−7−〔4′−フルオロ−5,6
−ジメトキシ−3−(プロパン−2−イル)ビフェニル
−2−イル〕−3,5−O−イソプロピリデン−3,5
−ジヒドロキシ−6−ヘプテン酸エチル(化合物(1
7))を129mg、収率59.4%で得た。さらにろ
液を濃縮しシリカゲルカラムにかけ酢酸エチルとヘキサ
ンの1:4混合溶媒で流し出したところ化合物(17)
を42mg、収率19.4%で得た。
7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-isopropylidene-3, synthesized in Example 1 Ethyl 5,7-trihydroxyheptanoate (Compound (16)) 225 mg (0.43 mmol) was added to 1,2.
-Dissolved in 4 ml of dichloroethane, 0.11 ml (1.30 mmol) of anhydrous pyridine and then 0.04 ml (0.49 mmol) of thionyl chloride were added at 0 ° C, and the mixture was stirred under an argon atmosphere for 50 minutes. The reaction mixture was poured into water and extracted with ethyl acetate. The extract layer was washed with aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was dissolved in 5 ml of 1,2-dichloroethane, 0.10 ml (1.24 mmol) of anhydrous pyridine was added, and the mixture was heated under reflux for 5 hours under an argon atmosphere. The reaction mixture was poured into water and extracted with ethyl acetate. The extract layer was washed successively with saturated brine, saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate and concentrated. The concentrate was crystallized from ethyl acetate and hexane to give (E) -7- [4'-fluoro-5,6
-Dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-isopropylidene-3,5
-Dihydroxy-6-heptenoate ethyl (compound (1
7)) was obtained in a yield of 129 mg and a yield of 59.4%. The filtrate was further concentrated, applied to a silica gel column, and poured out with a 1: 4 mixed solvent of ethyl acetate and hexane to give compound (17).
Was obtained in an amount of 42 mg in a yield of 19.4%.

【0060】融点:120.0〜121.0℃(無色針
状晶,酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 0.88 (dd,J=24.5 and 11.7
Hz,1H),1.20〜1.30(m,1H),1.
23(d,J=6.8Hz,6H),1.27(t,J
=7.2Hz,3H),1.34 (s,3H),1.4
3 (s,3H),2.30 (dd,J=15.5 an
d 6.2Hz,1H),2.49(dd,J=15.
5 and 7.0Hz,1H),3.25(hep
t,J=6.8Hz,1H),3.47(s,3H),
3.91(s,3H),4.09〜4.30 (m,4
H),5.13(dd,J=16.2 and 6.2
Hz,1H),6.22(dd,J=16.2 and
0.9Hz,1H),6.85(s,1H),6.9
8〜7.07 (m,2H),7.10〜7.20 (m,
1H)ppm IR(KBr):2964,2944,1738,16
02cm-1 Mass(m/z,%):500(M+ ,13),44
2(71),424(100),381(36),32
7(74),285(76),283(95),183
(24),43(45)
Melting point: 120.0-121.0 ° C. (colorless needle crystals, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 0.88 (dd, J = 24.5 and 11. 7
Hz, 1H), 1.20 to 1.30 (m, 1H), 1.
23 (d, J = 6.8 Hz, 6H), 1.27 (t, J
= 7.2 Hz, 3H), 1.34 (s, 3H), 1.4
3 (s, 3H), 2.30 (dd, J = 15.5 an
d 6.2 Hz, 1H), 2.49 (dd, J = 15.
5 and 7.0 Hz, 1H), 3.25 (hep)
t, J = 6.8 Hz, 1H), 3.47 (s, 3H),
3.91 (s, 3H), 4.09 to 4.30 (m, 4
H), 5.13 (dd, J = 16.2 and 6.2)
Hz, 1H), 6.22 (dd, J = 16.2 and
0.9Hz, 1H), 6.85 (s, 1H), 6.9
8 to 7.07 (m, 2H), 7.10 to 7.20 (m,
1H) ppm IR (KBr): 2964, 2944, 1738, 16
02 cm -1 Mass (m / z,%): 500 (M + , 13), 44
2 (71), 424 (100), 381 (36), 32
7 (74), 285 (76), 283 (95), 183
(24), 43 (45)

【0061】参考例12 (E)−7−〔4′−フルオロ−5,6−ジメトキシ−
3−(プロパン−2−イル)ビフェニル−2−イル〕−
3,5−ジヒドロキシ−6−ヘプテン酸エチル
Reference Example 12 (E) -7- [4'-fluoro-5,6-dimethoxy-
3- (propan-2-yl) biphenyl-2-yl]-
Ethyl 3,5-dihydroxy-6-heptenoate

【化28】 [Chemical 28]

【0062】実施例2で合成した(E)−7−〔4′−
フルオロ−5,6−ジメトキシ−3−(プロパン−2−
イル)ビフェニル−2−イル〕−3,5−O−イソプロ
ピリデン−3,5−ジヒドロキシ−6−ヘプテン酸エチ
ル化合物(17)51mg(0.10mmol)をTH
F2mlと水1mlの混合溶媒に溶解し、p−トルエン
スルホン酸一水和物18mg(0.10mmol)を加
えアルゴン雰囲気下室温にて4日間撹拌した。反応液を
水に投じ酢酸エチルで抽出した。抽出層を水、飽和炭酸
水素ナトリウム水溶液、飽和食塩水で順次洗浄、硫酸マ
グネシウム乾燥後濃縮した。濃縮物をシリカゲルカラム
にかけ酢酸エチルとヘキサンの1:1混合溶媒で流し出
したところ(E)−7−〔4′−フルオロ−5,6−ジ
メトキシ−3−(プロパン−2−イル)ビフェニル−2
−イル〕−3,5−ジヒドロキシ−6−ヘプテン酸エチ
ル(化合物(18))を34mg、収率72.5%で得
た。
(E) -7- [4'-synthesized in Example 2
Fluoro-5,6-dimethoxy-3- (propane-2-
IL) biphenyl-2-yl] -3,5-O-isopropylidene-3,5-dihydroxy-6-heptenoic acid ethyl compound (17) (51 mg, 0.10 mmol) was added to TH.
It was dissolved in a mixed solvent of 2 ml of F and 1 ml of water, 18 mg (0.10 mmol) of p-toluenesulfonic acid monohydrate was added, and the mixture was stirred at room temperature under an argon atmosphere for 4 days. The reaction solution was poured into water and extracted with ethyl acetate. The extract layer was washed successively with water, saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 1: 1 mixed solvent of ethyl acetate and hexane to obtain (E) -7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-. Two
-Yl] -3,5-dihydroxy-6-heptenoic acid ethyl ester (compound (18)) was obtained in an amount of 34 mg with a yield of 72.5%.

【0063】融点:77.0〜78.5℃(無色針状
晶,酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 1.22 (d,J=6.8Hz,3H),1.23
(d,J=6.8Hz,3H),1.15〜1.30
(m,1H),1.29 (t,J=7.2Hz,3
H),1.34〜1.49 (m,1H),2.32〜
2.48 (m,2H),2.75〜2.79 (m,1
H),3.22 (hept,J=6.8Hz,1H),
3.48 (s,3H),3.58 (s with fi
ne coupling,1H),3.91(s,3
H),4.00〜4.12 (m,1H),4.18
(q,J=7.2Hz,2H),4.22〜4.34
(m,1H),5.16 (dd,J=16.1 and
6.5Hz,1H),6.34 (dd,J=16.1
and 1.1Hz,1H),6.86 (s,1
H),7.00〜7.09 (m,2H),7.10〜
7.20 (m,2H)ppm IR(KBr):3432,1724cm-1 Mass(m/z,%):460 (M+ ,100),4
42 (88),327(51),285 (56),27
3 (65),243 (28),183 (17)
Melting point: 77.0 to 78.5 ° C. (colorless needle crystals, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 1.22 (d, J = 6.8 Hz, 3 H) , 1.23
(d, J = 6.8Hz, 3H), 1.15 to 1.30
(m, 1H), 1.29 (t, J = 7.2Hz, 3
H), 1.34 to 1.49 (m, 1H), 2.32 to
2.48 (m, 2H), 2.75 to 2.79 (m, 1
H), 3.22 (hept, J = 6.8 Hz, 1H),
3.48 (s, 3H), 3.58 (s with fi
ne coupling, 1H), 3.91 (s, 3
H), 4.00 to 4.12 (m, 1H), 4.18
(q, J = 7.2 Hz, 2H), 4.22 to 4.34
(m, 1H), 5.16 (dd, J = 16.1 and
6.5 Hz, 1 H), 6.34 (dd, J = 16.1)
and 1.1Hz, 1H), 6.86 (s, 1
H), 7.00 to 7.09 (m, 2H), 7.10
7.20 (m, 2H) ppm IR (KBr): 3432, 1724 cm -1 Mass (m / z,%): 460 (M + , 100), 4
42 (88), 327 (51), 285 (56), 27
3 (65), 243 (28), 183 (17)

【0064】参考例13 (E)−7−〔4′−フルオロ−5,6−ジメトキシ−
3−(プロパン−2−イル)ビフェニル−2−イル〕−
3,5−ジヒドロキシ−6−ヘプテン酸ナトリウム
Reference Example 13 (E) -7- [4'-Fluoro-5,6-dimethoxy-
3- (propan-2-yl) biphenyl-2-yl]-
Sodium 3,5-dihydroxy-6-heptenoate

【化29】 [Chemical 29]

【0065】参考例12で合成した(E)−7−〔4′
−フルオロ−5,6−ジメトキシ−3−(プロパン−2
−イル)ビフェニル−2−イル〕−3,5−ジヒドロキ
シ−6−ヘプテン酸エチル(化合物(18))122m
g(0.265mmol)をエタノール3mlに溶か
し、0.5N水酸化ナトリウム水溶液0.530ml
(0.265mmol)を加え、アルゴン雰囲気下、室
温で1時間25分間撹拌した。反応液を濃縮し、水に溶
かして凍結乾燥したところ、(E)−7−〔4′−フル
オロ−5,6−ジメトキシ−3−(プロパン−2−イ
ル)ビフェニル−2−イル〕−3,5−ジヒドロキシ−
6−ヘプテン酸ナトリウム(化合物(19))を117
mg、収率97.2%で無色不定形固体として得た。
(E) -7- [4 'synthesized in Reference Example 12
-Fluoro-5,6-dimethoxy-3- (propane-2
-Yl) biphenyl-2-yl] -3,5-dihydroxy-6-heptenoate ethyl (compound (18)) 122m
g (0.265 mmol) was dissolved in 3 ml of ethanol, and 0.530 ml of 0.5N sodium hydroxide aqueous solution was added.
(0.265 mmol) was added, and the mixture was stirred at room temperature for 1 hour and 25 minutes under an argon atmosphere. The reaction solution was concentrated, dissolved in water and freeze-dried to give (E) -7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3. , 5-dihydroxy-
117 sodium 6-heptenate (compound (19))
Obtained as a colorless amorphous solid in mg and yield of 97.2%.

【0066】1HNMR(300MHz,CD3 OD) δ 1.24 (d,J=6.8Hz,6H),1.20
〜1.31 (m,1H),1.45〜1.57 (m,1
H),2.16 (dd,J=15.4 and7.9H
z,1H),2.28 (dd,J=15.4 and
4.5Hz,1H),3.35 (hept,J=6.8
Hz,1H),3.45(s,3H),3.71〜3.
82 (m,1H),3.89 (s,3H),4.12〜
4.22 (m,1H),5.21 (dd,J=16.1
and 6.7Hz,1H),6.29 (dd,J=
16.1 and 1.1Hz,1H),6.95
(s,1H),7.04〜7.20 (m,4H)ppm IR(KBr):3456,2968,1574cm-1 Mass(FAB−negative,m/z,%):
453(〔M−H〕-,7),431 (100)
1 HNMR (300 MHz, CD 3 OD) δ 1.24 (d, J = 6.8 Hz, 6 H), 1.20
~ 1.31 (m, 1H), 1.45 to 1.57 (m, 1
H), 2.16 (dd, J = 15.4 and 7.9H)
z, 1H), 2.28 (dd, J = 15.4 and
4.5Hz, 1H), 3.35 (hept, J = 6.8)
Hz, 1H), 3.45 (s, 3H), 3.71-3.
82 (m, 1H), 3.89 (s, 3H), 4.12-
4.22 (m, 1H), 5.21 (dd, J = 16.1)
and 6.7 Hz, 1H), 6.29 (dd, J =
16.1 and 1.1 Hz, 1H), 6.95
(S, 1H), 7.04 to 7.20 (m, 4H) ppm IR (KBr): 3456, 2968, 1574 cm -1 Mass (FAB-negative, m / z,%):
453 ([M−H] , 7), 431 (100)

【0067】参考例14 (E)−8−フェニル−3,5−O−シクロヘキシリデ
ン−3,5−ジヒドロキシ−7−オクテン酸エチル
Reference Example 14 Ethyl (E) -8-phenyl-3,5-O-cyclohexylidene-3,5-dihydroxy-7-octenoate

【化30】 [Chemical 30]

【0068】参考例3で合成した(E)−3,5−ジヒ
ドロキシ−8−フェニル−7−オクテン酸エチル(化合
物(4))1.09g(3.92mmol)をシクロヘ
キサノンジメチルアセタール3mlに溶解しアルゴン気
流下室温で撹拌した溶液にp−トルエンスルホン酸一水
和物35mg(0.18mmol)を加え4時間25分
間撹拌した。反応混合物を水に投じ、酢酸エチルで抽出
した。抽出層を炭酸水素ナトリウム水溶液、水、飽和食
塩水で順次洗浄、硫酸マグネシウム乾燥後濃縮した。濃
縮物をシリカゲルカラムにかけヘキサンと酢酸エチルの
6:1混合溶媒で流し出し、再びシリカゲルカラムにか
けヘキサンと酢酸エチルの10:1混合溶媒で流し出し
たところ(E)−8−フェニル−3,5−O−シクロヘ
キシリデン−3,5−ジヒドロキシ−7−オクテン酸エ
チル(化合物(20))を1.14g、収率81.2%
で無色油状物として得た。
1.09 g (3.92 mmol) of ethyl (E) -3,5-dihydroxy-8-phenyl-7-octenoate (Compound (4)) synthesized in Reference Example 3 was dissolved in 3 ml of cyclohexanone dimethyl acetal. 35 mg (0.18 mmol) of p-toluenesulfonic acid monohydrate was added to the solution stirred at room temperature under an argon stream and stirred for 4 hours and 25 minutes. The reaction mixture was poured into water and extracted with ethyl acetate. The extract layer was washed successively with aqueous sodium hydrogen carbonate solution, water and saturated brine, dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column and poured out with a 6: 1 mixed solvent of hexane and ethyl acetate, and again poured onto a silica gel column with a mixed solvent of 10: 1 hexane and ethyl acetate (E) -8-phenyl-3,5. 1.14 g of ethyl -O-cyclohexylidene-3,5-dihydroxy-7-octenoate (compound (20)), yield 81.2%
To give a colorless oil.

【0069】1HNMR(300MHz,CDCl3 ) δ 1.18〜1.32 (m,1H),1.26 (t,
J=7.1Hz,3H),1.32〜1.50 (m,4
H),1.50〜1.67 (m,5H),1.72〜
1.86 (m,1H),1.94〜2.08 (m,1
H),2.25〜2.47 (m,2H),2.37 (d
d,J=15.3 and 5.3Hz,1H),2.
52(dd,J=15.3 and 7.7Hz,1
H),3.94〜4.07 (m,1H),4.10〜
4.20 (m,2H),4.27〜4.38 (m,1
H),6.23 (ddd,J=15.9,7.4 an
d 6.6Hz,1H),6.44 (d,J=15.9
Hz,1H),7.17〜7.38 (m,5H)ppm IR(液膜):2932,2860,1734,159
8cm-1 Mass(m/z,%):358(M+ ,14),24
1(100),155(64),143 (74),12
9 (38),99(48),91 (31),55(1
6)
1 HNMR (300 MHz, CDCl 3 ) δ 1.18 to 1.32 (m, 1H), 1.26 (t,
J = 7.1 Hz, 3 H), 1.32 to 1.50 (m, 4
H), 1.50 to 1.67 (m, 5H), 1.72 to
1.86 (m, 1H), 1.94 to 2.08 (m, 1
H), 2.25 to 2.47 (m, 2H), 2.37 (d
d, J = 15.3 and 5.3 Hz, 1H), 2.
52 (dd, J = 15.3 and 7.7 Hz, 1
H), 3.94 to 4.07 (m, 1H), 4.10
4.20 (m, 2H), 4.27 to 4.38 (m, 1
H), 6.23 (ddd, J = 15.9, 7.4 an
d 6.6 Hz, 1H), 6.44 (d, J = 15.9)
Hz, 1H), 7.17 to 7.38 (m, 5H) ppm IR (liquid film): 2932, 2860, 1734, 159
8 cm -1 Mass (m / z,%): 358 (M + , 14), 24
1 (100), 155 (64), 143 (74), 12
9 (38), 99 (48), 91 (31), 55 (1
6)

【0070】参考例15 7−オキソ−3,5−O−シクロヘキシリデン−3,5
−ジヒドロキシヘプタン酸エチル
Reference Example 15 7-oxo-3,5-O-cyclohexylidene-3,5
-Ethyl dihydroxyheptanoate

【化31】 [Chemical 31]

【0071】参考例14で合成した(E)−8−フェニ
ル−3,5−O−シクロヘキシリデン−3,5−ジヒド
ロキシ−7−オクテン酸エチル(化合物(20) )27
5mg(0.77mmol)をジクロロメタン7mlに
加え−78℃で撹拌した溶液に25分間オゾンを通し
た。反応混合物より過剰のオゾンを青色の溶液の色が無
色になるまで酸素でパージすることによって除いた後、
トリフェニルホスフィン241mg(0.92mmo
l)を加えた後室温にもどし1時間35分間撹拌した。
反応混合物を濃縮しシリカゲルカラムにかけヘキサンと
酢酸エチルの2:1混合溶媒で流し出したところ7−オ
キソ−3,5−O−シクロヘキシリデン−3,5−ジヒ
ドロキシヘプタン酸エチル(化合物(21))を199
mg、収率91.2%で無色油状物として得た。
Ethyl (E) -8-phenyl-3,5-O-cyclohexylidene-3,5-dihydroxy-7-octenoate (Compound (20)) 27 synthesized in Reference Example 14
5 mg (0.77 mmol) was added to 7 ml of dichloromethane, and ozone was passed through the solution stirred at -78 ° C for 25 minutes. After removing excess ozone from the reaction mixture by purging with oxygen until the color of the blue solution became colorless,
241 mg of triphenylphosphine (0.92 mmo
After adding 1), the mixture was returned to room temperature and stirred for 1 hour and 35 minutes.
The reaction mixture was concentrated, applied to a silica gel column, and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate. Ethyl 7-oxo-3,5-O-cyclohexylidene-3,5-dihydroxyheptanoate (compound (21) ) To 199
Obtained as a colorless oily substance with a yield of 91.2%.

【0072】1HNMR(300MHz,CDCl3 ) δ 1.22〜1.36 (m,1H),1.27 (t,
J=7.1Hz,3H),1.34〜1.50 (m,4
H),1.50〜1.63 (m,4H),1.66 (d
with fine coupling,J=12.
7Hz,1H),1.82〜2.05 (m,2H),
2.38(dd,J=15.3 and5.5Hz,1
H),2.42〜2.50 (m,1H),2.52 (d
d,J=15.3 and 7.7Hz,1H),2.
62(ddd,J=16.5,7.8 and 2.3
Hz,1H),4.08〜4.22 (m,2H),4.
32〜4.53 (m,2H),9.80 (s with
fine coupling,1H)ppm IR(液膜):2940,2864,1740cm-1 Mass(m/z,%):284(M+ ,53),24
1 (100),99 (29),81 (53),55 (2
7)
1 HNMR (300 MHz, CDCl 3 ) δ 1.22 to 1.36 (m, 1H), 1.27 (t,
J = 7.1 Hz, 3 H), 1.34 to 1.50 (m, 4
H), 1.50 to 1.63 (m, 4H), 1.66 (d
with fine coupling, J = 12.
7Hz, 1H), 1.82 to 2.05 (m, 2H),
2.38 (dd, J = 15.3 and 5.5 Hz, 1
H), 2.42 to 2.50 (m, 1H), 2.52 (d
d, J = 15.3 and 7.7 Hz, 1H), 2.
62 (ddd, J = 16.5, 7.8 and 2.3)
Hz, 1H), 4.08 to 4.22 (m, 2H), 4.
32-4.53 (m, 2H), 9.80 (s with
fine coupling, 1H) ppm IR (liquid film): 2940, 2864, 1740 cm -1 Mass (m / z,%): 284 (M + , 53), 24
1 (100), 99 (29), 81 (53), 55 (2
7)

【0073】実施例3 7−〔4′−フルオロ−5,6−ジメトキシ−3−(プ
ロパン−2−イル)ビフェニル−2−イル〕−3,5−
O−シクロヘキシリデン−3,5,7−トリヒドロキシ
ヘプタン酸エチル
Example 3 7- [4'-Fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-
Ethyl O-cyclohexylidene-3,5,7-trihydroxyheptanoate

【化32】 [Chemical 32]

【0074】マグネシウム(削り状)102mg(4.
90mmol)を無水THF1mlにけん濁し、アルゴ
ン気流下室温にて1,2−ジブロモエタン0.12ml
(1.40mmol)と参考例11で合成した2−ブロ
モ−4′−フルオロ−5,6−ジメトキシ−3−(プロ
パン−2−イル)ビフェニル(化合物(15))495
mg(1.40mmol)を8mlの無水THFに溶解
した溶液を10分間かけて滴下した。反応液を30分間
加熱還流した後室温にもどし、参考例15で合成した7
−オキソ−3,5−O−シクロヘキシリデン−3,5−
ジヒドロキシヘプタン酸エチル(化合物(21))33
3mg(1.17mmol)を4mlの無水THFに溶
解して加え、3時間15分間撹拌した。反応液を1N塩
酸に投じ酢酸エチルで抽出した。抽出層を水、飽和炭酸
水素ナトリウム水溶液、水、飽和食塩水で順次洗浄、硫
酸マグネシウム乾燥後濃縮した。濃縮物をシリカゲルカ
ラムにかけ酢酸エチルとヘキサンの1:6続いて1:2
の混合溶媒で流し出したところ7−〔4′−フルオロ−
5,6−ジメトキシ−3−(プロパン−2−イル)ビフ
ェニル−2−イル〕−3,5−O−シクロヘキシリデン
−3,5,7−トリヒドロキシヘプタン酸エチル(化合
物(22))を242mg、37.1%の収率で無色不
定形固体として得た。
Magnesium (cutting) 102 mg (4.
90 mmol) was suspended in 1 ml of anhydrous THF, and 0.12 ml of 1,2-dibromoethane was added at room temperature under an argon stream.
(1.40 mmol) and 2-bromo-4′-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl (compound (15)) 495 synthesized in Reference Example 11.
A solution of mg (1.40 mmol) dissolved in 8 ml of anhydrous THF was added dropwise over 10 minutes. The reaction solution was heated under reflux for 30 minutes and then returned to room temperature to synthesize 7 in Reference Example 15.
-Oxo-3,5-O-cyclohexylidene-3,5-
Ethyl dihydroxyheptanoate (Compound (21)) 33
3 mg (1.17 mmol) was dissolved in 4 ml of anhydrous THF and added, and the mixture was stirred for 3 hours and 15 minutes. The reaction solution was poured into 1N hydrochloric acid and extracted with ethyl acetate. The extract layer was washed successively with water, saturated aqueous sodium hydrogen carbonate solution, water and saturated brine, dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column with 1: 6 ethyl acetate and hexane followed by 1: 2.
When it was poured out with a mixed solvent of 7- [4'-fluoro-
Ethyl 5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-cyclohexylidene-3,5,7-trihydroxyheptanoate (Compound (22)) Obtained as a colorless amorphous solid in a yield of 242 mg, 37.1%.

【0075】7:3の立体異性体の混合物1 HNMR(300MHz,CDCl3 ) δ 0.96〜1.09 (m,0.7H),1.10〜
1.22 (m,0.3H),1.23〜1.39 (m,
15H),1.39〜1.62 (m,4H),1.69
〜1.90 (m,2H),2.07〜2.23 (m,1
H),2.24〜2.37 (m,1H),2.40〜
2.52 (m,1H),3.13〜3.16 (m,0.
3H),3.47 (s,3H),3.72〜3.98
(m,1H),3.89 (s,3H),4.03〜4.
20 (m,3H),4.20〜4.32 (m,1H),
4.70〜4.76 (m,0.3H),4.93〜5.
02 (m,0.7H),6.91 (s,1H),7.0
0〜7.34 (m,4H)ppm IR(KBr):3532,2940,2868,17
40,1592cm-1Mass(m/z,%):558
(M+ ,16),540 (40),442 (100),
424(76),327 (76),285 (75),2
83 (86),55 (34)
Mixture of 7: 3 stereoisomers 1 HNMR (300 MHz, CDCl 3 ) δ 0.96 to 1.09 (m, 0.7H), 1.10
1.22 (m, 0.3H), 1.23 to 1.39 (m,
15H), 1.39 to 1.62 (m, 4H), 1.69
~ 1.90 (m, 2H), 2.07 to 2.23 (m, 1
H), 2.24 to 2.37 (m, 1H), 2.40 to
2.52 (m, 1H), 3.13 to 3.16 (m, 0.
3H), 3.47 (s, 3H), 3.72 to 3.98.
(m, 1H), 3.89 (s, 3H), 4.03-4.
20 (m, 3H), 4.20 to 4.32 (m, 1H),
4.70-4.76 (m, 0.3H), 4.93-5.
02 (m, 0.7H), 6.91 (s, 1H), 7.0
0-7.34 (m, 4H) ppm IR (KBr): 3532, 2940, 2868, 17
40,1592 cm -1 Mass (m / z,%): 558
(M + , 16), 540 (40), 442 (100),
424 (76), 327 (76), 285 (75), 2
83 (86), 55 (34)

【0076】実施例4 (E)−7−〔4′−フルオロ−5,6−ジメトキシ−
3−(プロパン−2−イル)ビフェニル−2−イル〕−
3,5−O−シクロヘキシリデン−3,5−ジヒドロキ
シ−6−ヘプテン酸エチル
Example 4 (E) -7- [4'-fluoro-5,6-dimethoxy-
3- (propan-2-yl) biphenyl-2-yl]-
Ethyl 3,5-O-cyclohexylidene-3,5-dihydroxy-6-heptenoate

【化33】 [Chemical 33]

【0077】実施例3で合成した7−〔4′−フルオロ
−5,6−ジメトキシ−3−(プロパン−2−イル)ビ
フェニル−2−イル〕−3,5−O−シクロヘキシリデ
ン−3,5,7−トリヒドロキシヘプタン酸エチル(化
合物(22))77mg(0.14mmol)を1,2
−ジクロロエタン2mlに溶解し、0℃にて無水ピリジ
ン0.03ml(0.37mmol)、続いて塩化チオ
ニル0.01ml(0.15mmol)を加えアルゴン
雰囲気下30分間撹拌した。反応液を水に投じ酢酸エチ
ルで抽出した。抽出層を炭酸水素ナトリウム水溶液、飽
和食塩水で順次洗浄、硫酸マグネシウム乾燥後濃縮し
た。濃縮物を1,2−ジクロロエタン3mlに溶解し、
無水ピリジン0.03ml(0.37mmol)を加え
アルゴン雰囲気下2時間加熱還流した。反応液を水に投
じ酢酸エチルで抽出した。抽出層を飽和食塩水で洗浄、
硫酸マグネシウム乾燥後濃縮した。濃縮物をシリカゲル
カラムにかけ酢酸エチルとヘキサンの1:4混合溶媒で
流し出したところ(E)−7−〔4′−フルオロ−5,
6−ジメトキシ−3−(プロパン−2−イル)ビフェニ
ル−2−イル〕−3,5−O−シクロヘキシリデン−
3,5−ジヒドロキシ−6−ヘプテン酸エチル(化合物
(23))を53mg、収率71.1%で得た。
7- [4'-Fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-cyclohexylidene-3 synthesized in Example 3 77 mg (0.14 mmol) of ethyl 5,5,7-trihydroxyheptanoate (Compound (22)) was added to 1,2.
-Dissolved in 2 ml of dichloroethane, 0.03 ml (0.37 mmol) of anhydrous pyridine and then 0.01 ml (0.15 mmol) of thionyl chloride were added at 0 ° C, and the mixture was stirred under an argon atmosphere for 30 minutes. The reaction solution was poured into water and extracted with ethyl acetate. The extract layer was washed successively with aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and concentrated. Dissolve the concentrate in 3 ml of 1,2-dichloroethane,
Anhydrous pyridine (0.03 ml, 0.37 mmol) was added, and the mixture was heated under reflux for 2 hours under an argon atmosphere. The reaction solution was poured into water and extracted with ethyl acetate. Wash the extract layer with saturated saline,
The extract was dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column and poured out with a 1: 4 mixed solvent of ethyl acetate and hexane to obtain (E) -7- [4'-fluoro-5,5.
6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-cyclohexylidene-
53 mg of ethyl 3,5-dihydroxy-6-heptenoate (Compound (23)) was obtained at a yield of 71.1%.

【0078】融点:118.0〜118.5℃(無色微
粒状晶、酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 0.97 (dd,J=24.4 and 11.7
Hz,1H),1.22(d,J=6.8Hz,3
H),1.22(d,J=6.8Hz,3H),1.2
7(t,J=7.2Hz,3H),1.27〜1.46
(m,5H),1.46〜1.57(m,4H),1.
75〜1.95 (m,2H),2.32(dd,J=1
5.4 and 5.6Hz,1H),2.47 (d
d,J=15.4 and 7.6Hz,1H),3.
25(hept,J=6.8Hz,1H),3.48
(s,3H),3.91(s,3H),4.15(q,
J=7.2Hz,2H),4.20〜4.33 (m,2
H),5.15(dd,J=16.2 and 6.2
Hz,1H),6.23(dd,J=16.2 and
1.1Hz,1H),6.85(s,1H),6.9
7〜7.05 (m,2H),7.10〜7.18 (m,
2H)ppm IR(KBr):2948,2856,1740,16
06,1588cm-1Mass(m/z,%):540
(M+ ,100),442 (72),399(31),
285 (48),283 (31),55 (8)
Melting point: 118.0 to 118.5 ° C. (colorless fine-grained crystals, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 0.97 (dd, J = 24.4 and 11. 7
Hz, 1H), 1.22 (d, J = 6.8Hz, 3
H), 1.22 (d, J = 6.8 Hz, 3H), 1.2
7 (t, J = 7.2 Hz, 3H), 1.27 to 1.46
(M, 5H), 1.46 to 1.57 (m, 4H), 1.
75-1.95 (m, 2H), 2.32 (dd, J = 1
5.4 and 5.6 Hz, 1H), 2.47 (d
d, J = 15.4 and 7.6 Hz, 1H), 3.
25 (hept, J = 6.8 Hz, 1H), 3.48
(S, 3H), 3.91 (s, 3H), 4.15 (q,
J = 7.2 Hz, 2H), 4.20-4.33 (m, 2
H), 5.15 (dd, J = 16.2 and 6.2)
Hz, 1H), 6.23 (dd, J = 16.2 and
1.1 Hz, 1H), 6.85 (s, 1H), 6.9
7 to 7.05 (m, 2H), 7.10 to 7.18 (m,
2H) ppm IR (KBr): 2948, 2856, 1740, 16
06,1588 cm -1 Mass (m / z,%): 540
(M + , 100), 442 (72), 399 (31),
285 (48), 283 (31), 55 (8)

【0079】参考例16 (E)−3,5−ジオキソ−8−フェニル−7−オクテ
ン酸t−ブチル
Reference Example 16 t-Butyl (E) -3,5-dioxo-8-phenyl-7-octenoate

【化34】 [Chemical 34]

【0080】水素化ナトリウム(60%)1.78g
(44.5mmol)を無水THF70mlに懸濁した
溶液にアルゴン気流下0℃でアセト酢酸t−ブチル8.
10ml(48.8mmol)を加え室温で30分間撹
拌した。この溶液を0℃に冷却し、ブチルリチウム
(1.66Mヘキサン溶液)28.5ml(47.3m
mol)を加え20分間撹拌した。溶液を−78℃に冷
却し、参考例1で合成した(E)−N−メトキシ−N−
メチル−4−フェニル−3−ブテンアミド(化合物
(2))5.88g(28.7mmol)を無水THF
30mlに溶解して15分間かけて加え、1時間35分
間撹拌した。反応混合物を希塩酸に投じ酢酸エチルで抽
出した。抽出層を飽和食塩水で洗浄、硫酸マグネシウム
乾燥後濃縮した。濃縮物をシリカゲルカラムにかけヘキ
サンと酢酸エチルの5:1混合溶媒で流し出し得られた
粗精製物を再びシリカゲルカラムにかけジクロロメタン
と酢酸エチルの100:1混合溶媒で流し出したとこ
ろ、(E)−3,5−ジオキソ−8−フェニル−7−オ
クテン酸t−ブチル(化合物(24))を5.05g、
収率58.3%で無色油状物として得た。
1.78 g of sodium hydride (60%)
(44.5 mmol) was suspended in 70 ml of anhydrous THF, and t-butyl acetoacetate was added thereto at 0 ° C. under an argon stream.
10 ml (48.8 mmol) was added and the mixture was stirred at room temperature for 30 minutes. This solution was cooled to 0 ° C., and 28.5 ml (47.3 m) of butyllithium (1.66M hexane solution).
(mol) and stirred for 20 minutes. The solution was cooled to −78 ° C. and synthesized (E) -N-methoxy-N-in Reference Example 1.
Methyl-4-phenyl-3-butenamide (compound (2)) (5.88 g, 28.7 mmol) was added to anhydrous THF.
It was dissolved in 30 ml, added over 15 minutes, and stirred for 1 hour and 35 minutes. The reaction mixture was poured into diluted hydrochloric acid and extracted with ethyl acetate. The extract layer was washed with saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 5: 1 mixed solvent of hexane and ethyl acetate. The resulting crude product was again applied to a silica gel column and poured out with a mixed solvent of 100: 1 dichloromethane and ethyl acetate, and (E)- 5.05 g of t-butyl 3,5-dioxo-8-phenyl-7-octenoate (compound (24)),
Obtained as a colorless oil in a yield of 58.3%.

【0081】1HNMR(300MHz,CDCl3
ケト:エノール 15:85の混合物 δ 1.45(s,7.65H),1.46(s,1.
35H),3.10〜3.18 (m,1.7H),3.
25(s,1.7H),3.44(dd,J=7.1
and 1.2Hz,0.3H),3.47(s,0.
3H),3.79(s,0.3H),5.66 (s,
0.85H),6.25 (dt,J=15.8 and
7.2Hz,0.85H),6.19〜6.32
(m,0.15H),6.51 (d,J=15.8H
z,1H),7.20〜7.41 (m,5H)ppm IR(液膜):2984,2936,1732,160
4cm-1 Mass(m/z,%):302(M+ ,1),246
(14),229 (11),185(26),129
(100),117 (25),57 (35)
1 HNMR (300 MHz, CDCl 3 )
Keto: enol 15:85 mixture δ 1.45 (s, 7.65H), 1.46 (s, 1.
35H), 3.10 to 3.18 (m, 1.7H), 3.
25 (s, 1.7H), 3.44 (dd, J = 7.1)
and 1.2 Hz, 0.3 H), 3.47 (s, 0.
3H), 3.79 (s, 0.3H), 5.66 (s,
0.85H), 6.25 (dt, J = 15.8 and
7.2 Hz, 0.85 H), 6.19 to 6.32
(m, 0.15H), 6.51 (d, J = 15.8H
z, 1H), 7.20 to 7.41 (m, 5H) ppm IR (liquid film): 2984, 2936, 1732, 160
4 cm -1 Mass (m / z,%): 302 (M + , 1), 246
(14), 229 (11), 185 (26), 129
(100), 117 (25), 57 (35)

【0082】参考例17 (E)−3,5−ジヒドロキシ−8−フェニル−7−オ
クテン酸t−ブチル
Reference Example 17 t-Butyl (E) -3,5-dihydroxy-8-phenyl-7-octenoate

【化35】 [Chemical 35]

【0083】参考例16で合成した(E)−3,5−ジ
オキソ−8−フェニル−7−オクテン酸t−ブチル(化
合物(24))4.67g(15.5mmol)を無水
THF20mlとメタノール10mlに溶解した溶液に
アルゴン気流下−78℃でジエチルメトキシボラン
(1.0M THF溶液)18.5ml(18.5mm
ol)を加えた後、−78℃の冷却バスをはずし、室温
で30分間撹拌した。この溶液を再び−78℃に冷却し
水素化ホウ素ナトリウム1.20g(31.7mmo
l)を2回に分けて加え、5時間撹拌した。反応混合物
を0℃で撹拌した30%過酸化水素水180mlに徐々
に加え室温で一晩撹拌した。反応混合物を飽和食塩水に
投じ酢酸エチルで抽出した。抽出層を飽和食塩水、チオ
硫酸ナトリウム水溶液および飽和食塩水で順次洗浄し硫
酸マグネシウム乾燥後濃縮した。濃縮物をシリカゲルカ
ラムにかけ、ヘキサンと酢酸エチルの1:1混合溶媒で
流し出したところ、(E)−3,5−ジヒドロキシ−8
−フェニル−7−オクテン酸t−ブチル(化合物(2
5))を3.80g、収率80.8%で無色油状物とし
て得た。
4.67 g (15.5 mmol) of t-butyl (E) -3,5-dioxo-8-phenyl-7-octenoate (Compound (24)) synthesized in Reference Example 16 was added to 20 ml of anhydrous THF and 10 ml of methanol. The solution dissolved in was dissolved in 18.5 ml (18.5 mm) of diethylmethoxyborane (1.0 M THF solution) at -78 ° C under an argon stream.
ol) was added, the cooling bath at −78 ° C. was removed, and the mixture was stirred at room temperature for 30 minutes. The solution was cooled again to -78 ° C and sodium borohydride (1.20 g, 31.7 mmo).
1) was added in 2 portions and the mixture was stirred for 5 hours. The reaction mixture was gradually added to 180 ml of 30% aqueous hydrogen peroxide stirred at 0 ° C., and the mixture was stirred overnight at room temperature. The reaction mixture was poured into saturated saline and extracted with ethyl acetate. The extract layer was washed successively with saturated brine, aqueous sodium thiosulfate solution and saturated brine, dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column and poured out with a 1: 1 mixed solvent of hexane and ethyl acetate to obtain (E) -3,5-dihydroxy-8.
T-butyl phenyl-7-octenoate (compound (2
5)) was obtained as a colorless oily substance in 3.80 g in a yield of 80.8%.

【0084】1HNMR(300MHz,CDCl3 ) δ 1.46(s,9H),1.54〜1.68 (m,
2H),2.35〜2.46 (m,4H),3.48
(s,1H),3.82 (d,J=2.4Hz,1
H),3.94〜4.08 (m,1H),4.18〜
4.31 (m,1H),6.24 (dt,J=15.9
and 7.2Hz,1H),6.46 (d,J=1
5.9Hz,1H),7.17〜7.39 (m,5H)
ppm IR(液膜):3448,2980,2936,172
8,1600cm-1Mass(FAB−pogitiv
e,m/z,%):307 (〔M+H〕+,5) Mass(m/z,%):270(M+ −36,25)
,133(45) ,118(44),117(4
2),115(100),57(60)
1 HNMR (300 MHz, CDCl 3 ) δ 1.46 (s, 9H), 1.54 to 1.68 (m,
2H), 2.35 to 2.46 (m, 4H), 3.48
(s, 1H), 3.82 (d, J = 2.4Hz, 1
H), 3.94 to 4.08 (m, 1H), 4.18 to
4.31 (m, 1H), 6.24 (dt, J = 15.9)
and 7.2 Hz, 1H), 6.46 (d, J = 1)
5.9 Hz, 1H), 7.17 to 7.39 (m, 5H)
ppm IR (liquid film): 3448, 2980, 2936, 172
8,1600 cm -1 Mass (FAB-positiv
e, m / z,%): 307 ([M + H] + , 5) Mass (m / z,%): 270 (M + -36, 25)
, 133 (45), 118 (44), 117 (4
2), 115 (100), 57 (60)

【0085】参考例18 (E)−8−フェニル−3,5−O−イソプロピリデン
−3,5−ジヒドロキシ−7−オクテン酸t−ブチル
Reference Example 18 (E) -8-phenyl-3,5-O-isopropylidene-3,5-dihydroxy-7-octenoate t-butyl ester

【化36】 [Chemical 36]

【0086】参考例17で合成した(E)−3,5−ジ
ヒドロキシ−8−フェニル−7−オクテン酸t−ブチル
(化合物(25))740mg(2.43mmol)を
2,2−ジメトキシプロパン7.0mlに溶解し、アル
ゴン気流下室温で撹拌した溶液にp−トルエンスルホン
酸一水和物5mg(0.03mmol)を加え、1時間
撹拌した。反応混合物を炭酸水素ナトリウム水溶液に投
じ酢酸エチルで抽出した。抽出層を飽和食塩水で洗浄、
硫酸マグネシウム乾燥後濃縮した。濃縮物をシリカゲル
カラムにかけ、ヘキサンと酢酸エチルの3:1混合溶液
で流し出したところ、(E)−8−フェニル−3,5−
O−イソプロピリデン−3,5−ジヒドロキシ−7−オ
クテン酸t−ブチル(化合物(26))を784mg、
93.6%の収率で無色油状物として得た。
740 mg (2.43 mmol) of (E) -3,5-dihydroxy-8-phenyl-7-octenoate t-butyl (Compound (25)) synthesized in Reference Example 17 was added to 2,2-dimethoxypropane 7 5 mg (0.03 mmol) of p-toluenesulfonic acid monohydrate was added to the solution dissolved in 0.0 ml and stirred at room temperature under an argon stream, and stirred for 1 hour. The reaction mixture was poured into an aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. Wash the extract layer with saturated saline,
The extract was dried over magnesium sulfate and concentrated. The concentrate was applied to a silica gel column and was poured out with a 3: 1 mixed solution of hexane and ethyl acetate, whereby (E) -8-phenyl-3,5-
784 mg of t-butyl O-isopropylidene-3,5-dihydroxy-7-octenoate (compound (26)),
Obtained as a colorless oil in a yield of 93.6%.

【0087】1HNMR(300MHz,CDCl3 ) δ 1.16〜1.30 (m,1H),1.40 (s,
3H),1.43 (s,9H),1.47 (s,3
H),1.62 (dt,J=12.8 and 2.4
Hz,1H),2.30(dd,J=15.0 and
6.0Hz,1H),2.25〜2.52 (m,2
H),2.43 (dd,J=15.0 and7.2H
z,1H),3.97 (dtd,J=11.5,6.2
and 2.4Hz,1H),4.20〜4.32
(m,1H),6.14〜6.28 (m,1H),6.
43 (d,J=15.9Hz,1H),7.17〜7.
38 (m,5H)ppm IR(液膜):2984,2940,1732cm-1 Mass(FAB−positive,m/z,%):
347 (〔M+H〕+,2) Mass(m/z,%);331(M+ −15,9),
215(32),173(100),155(26),
115(57),57(30)
1 HNMR (300 MHz, CDCl 3 ) δ 1.16 to 1.30 (m, 1H), 1.40 (s,
3H), 1.43 (s, 9H), 1.47 (s, 3
H), 1.62 (dt, J = 12.8 and 2.4)
Hz, 1H), 2.30 (dd, J = 15.0 and
6.0 Hz, 1 H), 2.25 to 2.52 (m, 2
H), 2.43 (dd, J = 15.0 and 7.2H
z, 1H), 3.97 (dtd, J = 11.5, 6.2)
and 2.4 Hz, 1H), 4.20 to 4.32.
(m, 1H), 6.14 to 6.28 (m, 1H), 6.
43 (d, J = 15.9 Hz, 1H), 7.17 to 7.
38 (m, 5H) ppm IR (liquid film): 2984, 2940, 1732 cm -1 Mass (FAB-positive, m / z,%):
347 ([M + H] + , 2) Mass (m / z,%); 331 (M + -15, 9),
215 (32), 173 (100), 155 (26),
115 (57), 57 (30)

【0088】参考例19 7−オキソ−3,5−O−イソプロピリデン−3,5−
ジヒドロキシヘプタン酸t−ブチル
Reference Example 19 7-oxo-3,5-O-isopropylidene-3,5-
T-Butyl dihydroxyheptanoate

【化37】 [Chemical 37]

【0089】参考例18で合成した(E)−8−フェニ
ル−3,5−O−イソプロピリデン−3,5−ジヒドロ
キシ−7−オクテン酸t−ブチル(化合物(26))7
34mg(2.13mmol)をジクロロメタン40m
lに加え、−78℃で撹拌した溶液に30分間オゾンを
通した。反応混合物より過剰のオゾンを青色の溶液の色
が無色になるまで酸素でパージすることにより除いた
後、トリフェニルホスフィン670mg(2.55mm
ol)を加え、2時間撹拌後0℃で一晩放置した。反応
混合物を濃縮し、シリカゲルカラムにかけ、ヘキサンと
酢酸エチルの2:1混合溶媒で流し出したところ7−オ
キソ−3,5−O−イソプロピリデン−3,5−ジヒド
ロキシヘプタン酸t−ブチル(化合物(27))を49
5mg、85.3%の収率で無色油状物として得た。
(E) -8-phenyl-3,5-O-isopropylidene-3,5-dihydroxy-7-octenoate t-butyl (Compound (26)) 7 synthesized in Reference Example 18
34 mg (2.13 mmol) of dichloromethane 40 m
In addition to 1 liter, ozone was passed through the solution stirred at -78 ° C for 30 minutes. Excess ozone was removed from the reaction mixture by purging with oxygen until the color of the blue solution became colorless, then 670 mg of triphenylphosphine (2.55 mm
ol) was added and the mixture was stirred for 2 hours and left overnight at 0 ° C. The reaction mixture was concentrated, applied to a silica gel column, and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate, whereby t-butyl 7-oxo-3,5-O-isopropylidene-3,5-dihydroxyheptanoate (compound (27)) to 49
Obtained as a colorless oil in a yield of 5 mg, 85.3%.

【0090】1HNMR(300MHz,CDCl3 ) δ 1.20〜1.34 (m,1H),1.36 (s,
3H),1.45 (s,9H),1.48 (s,3
H),1.66(dt,J=12.7 and 2.5
Hz,1H),2.31 (dd,J=15.1 and
6.1Hz,1H),2.43(dd,J=15.1
and 7.1Hz,1H),2.47 (ddd,J
=16.7,5.0 and 1.7Hz,1H),
2.62 (ddd,J=16.7,7.3 and
2.3Hz,1H),4.25〜4.36(m,1
H),4.38〜4.48 (m,1H),9.78 (d
d,J=2.3and 1.7Hz,1H)ppm IR(液膜):2988,2944,1726cm-1 Mass(FAB−positive,m/z,%):
273 (〔M+H〕+,19) Mass(m/z,%):257(M+ −15,6
2),201(42),149(61),141(4
6),59(34),57(70)
1 HNMR (300 MHz, CDCl 3 ) δ 1.20 to 1.34 (m, 1H), 1.36 (s,
3H), 1.45 (s, 9H), 1.48 (s, 3
H), 1.66 (dt, J = 12.7 and 2.5)
Hz, 1H), 2.31 (dd, J = 15.1 and
6.1 Hz, 1 H), 2.43 (dd, J = 15.1)
and 7.1 Hz, 1H), 2.47 (ddd, J
= 16.7, 5.0 and 1.7 Hz, 1H),
2.62 (ddd, J = 16.7, 7.3 and
2.3 Hz, 1 H), 4.25 to 4.36 (m, 1
H), 4.38 to 4.48 (m, 1H), 9.78 (d
d, J = 2.3 and 1.7 Hz, 1 H) ppm IR (liquid film): 2988, 2944, 1726 cm -1 Mass (FAB-positive, m / z,%):
273 ([M + H] + , 19) Mass (m / z,%): 257 (M + -15, 6)
2), 201 (42), 149 (61), 141 (4
6), 59 (34), 57 (70)

【0091】実施例5 7−〔4′−フルオロ−5,6−ジメトキシ−3−(プ
ロパン−2−イル)ビフェニル−2−イル〕−3,5−
O−イソプロピリデン−3,5,7−トリヒドロキシヘ
プタン酸t−ブチル
Example 5 7- [4'-Fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-
T-Butyl O-isopropylidene-3,5,7-trihydroxyheptanoate

【化38】 [Chemical 38]

【0092】参考例11で合成した2−ブロモ−4′−
フルオロ−5,6−ジメトキシ−3−(プロパン−2−
イル)ビフェニル(化合物(15))750mg(2.
11mmol)およびマグネシウム(削り状)213m
g(8.76mmol)を無水THF4mlに加えアル
ゴン雰囲気下加熱還流した溶液に、1,2−ジブロモエ
タン0.27ml(2.10mmol)を無水THF4
mlに溶解して5分間かけて加え、1時間加熱還流し
た。この溶液に参考例19で合成した7−オキソ−3,
5−O−イソプロピリデン−3,5−ジヒドロキシヘプ
タン酸t−ブチル(化合物(27))460mg(1.
69mmol)を無水THF2mlに溶解して加えた後
室温で1時間撹拌した。反応混合物を飽和塩化アンモニ
ウム水溶液に投じ酢酸エチルで抽出した。抽出層を飽和
食塩水で洗浄、硫酸マグネシウム乾燥後濃縮した。濃縮
物をシリカゲルカラムにかけヘキサンと酢酸エチルの
2:1混合溶媒で流し出したところ、7−〔4′−フル
オロ−5,6−ジメトキシ−3−(プロパン−2−イ
ル)ビフェニル−2−イル〕−3,5−O−イソプロピ
リデン−3,5,7−トリヒドロキシヘプタン酸t−ブ
チル(化合物(28))を670mg、72.4%の収
率で無色不定形固体として得た。
2-Bromo-4'-synthesized in Reference Example 11
Fluoro-5,6-dimethoxy-3- (propane-2-
Yl) biphenyl (compound (15)) 750 mg (2.
11 mmol) and magnesium (cutting) 213 m
g (8.76 mmol) was added to anhydrous THF (4 ml), and the solution was heated to reflux under an argon atmosphere, and 1,2-dibromoethane (0.27 ml, 2.10 mmol) was added to anhydrous THF (4).
It was dissolved in ml, added over 5 minutes, and heated under reflux for 1 hour. 7-oxo-3 synthesized in Reference Example 19 in this solution,
T-butyl 5-O-isopropylidene-3,5-dihydroxyheptanoate (Compound (27)) 460 mg (1.
69 mmol) was dissolved in 2 ml of anhydrous THF and added, and the mixture was stirred at room temperature for 1 hour. The reaction mixture was poured into saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The extract layer was washed with saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate to give 7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl. ] Tert-Butyl-3,5-O-isopropylidene-3,5,7-trihydroxyheptanoate (Compound (28)) was obtained as a colorless amorphous solid in a yield of 670 mg and 72.4%.

【0093】1:1の立体異性体の混合物1 HNMR(CDCl3 ,300MHz) δ 0.84〜1.18 (m,1H),1.20〜1.
48 (m,13H),1.43 (s,4.5H),1.
45 (s,4.5H),2.04〜2.44 (m,4
H),2.92 (d,J=1.6Hz,0.5H),
3.46(s,1.5H),3.47 (s,1.5
H),3.89(s,3H),3.70〜4.25
(m,3H),4.68〜4.78 (m,0.5H),
4.87〜4.97 (m,0.5H),6.91 (s,
1H),7.00〜7.23 (m,4H)ppm IR(KBr):3524,2960,1732,15
90cm-1 Mass(m/z,%):546(M+ ,36),52
8 (20),470 (28),414 (69),371
(28),303 (100),302 (49),301
(39),285(77),57(32)
Mixture of 1: 1 stereoisomers 1 HNMR (CDCl 3 , 300 MHz) δ 0.84 to 1.18 (m, 1H), 1.20 to 1.
48 (m, 13H), 1.43 (s, 4.5H), 1.
45 (s, 4.5H), 2.04 to 2.44 (m, 4
H), 2.92 (d, J = 1.6Hz, 0.5H),
3.46 (s, 1.5H), 3.47 (s, 1.5
H), 3.89 (s, 3H), 3.70 to 4.25.
(m, 3H), 4.68 to 4.78 (m, 0.5H),
4.87-4.97 (m, 0.5H), 6.91 (s,
1H), 7.00 to 7.23 (m, 4H) ppm IR (KBr): 3524, 2960, 1732, 15
90 cm -1 Mass (m / z,%): 546 (M + , 36), 52
8 (20), 470 (28), 414 (69), 371
(28), 303 (100), 302 (49), 301
(39), 285 (77), 57 (32)

【0094】実施例6 7−〔4′−フルオロ−5,6−ジメトキシ−3−(プ
ロパン−2−イル)ビフェニル−2−イル〕−3,5−
O−イソプロピリデン−6−ヘプテン酸t−ブチル
Example 6 7- [4'-Fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-
T-Butyl O-isopropylidene-6-heptenoate

【化39】 [Chemical Formula 39]

【0095】実施例5で合成した7−〔4′−フルオロ
−5,6−ジメトキシ−3−(プロパン−2−イル)ビ
フェニル−2−イル〕−3,5−O−イソプロピリデン
−3,5,7−トリヒドロキシヘプタン酸t−ブチル
(化合物(28))、208mg(0.38mmol)
を1,2−ジクロロエタン2.5mlに溶解し、アルゴ
ン雰囲気下、0℃にて無水ピリジン0.10ml(1.
24mmol)、続いて塩化チオニル0.03ml
(0.41mmol)を加え、1時間撹拌した。反応溶
液を飽和食塩水に投じ酢酸エチルで抽出した。抽出層を
炭酸水素ナトリウム水溶液および飽和食塩水で洗浄、硫
酸マグネシウム乾燥後濃縮した。濃縮物を1,2−ジク
ロロエタン3mlに溶解し、無水ピリジン0.10ml
(1.26mmol)を加えアルゴン雰囲気下で2時間
加熱還流した。反応混合物を飽和食塩水に投じ酢酸エチ
ルで抽出した。抽出層を飽和食塩水で洗浄、硫酸マグネ
シウム乾燥後濃縮した。濃縮物をシリカゲルカラムにか
けヘキサンと酢酸エチルの2:1混合溶媒で流し出した
ところ7−〔4′−フルオロ−5,6−ジメトキシ−3
−(プロパン−2−イル)ビフェニル−2−イル〕−
3,5−O−イソプロピリデン−6−ヘプテン酸t−ブ
チル(化合物(29) )を157mg、78.0%の収
率で得た。
7- [4'-fluoro-5,6-dimethoxy-3- (propan-2-yl) biphenyl-2-yl] -3,5-O-isopropylidene-3, synthesized in Example 5 T-Butyl 5,7-trihydroxyheptanoate (Compound (28)), 208 mg (0.38 mmol)
Was dissolved in 2.5 ml of 1,2-dichloroethane, and 0.10 ml of anhydrous pyridine (1.
24 mmol), followed by 0.03 ml of thionyl chloride
(0.41 mmol) was added and stirred for 1 hour. The reaction solution was poured into saturated saline and extracted with ethyl acetate. The extract layer was washed with aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was dissolved in 3 ml of 1,2-dichloroethane and 0.10 ml of anhydrous pyridine was added.
(1.26 mmol) was added and the mixture was heated under reflux for 2 hours under an argon atmosphere. The reaction mixture was poured into saturated saline and extracted with ethyl acetate. The extract layer was washed with saturated brine, dried over magnesium sulfate, and concentrated. The concentrate was applied to a silica gel column and poured out with a 2: 1 mixed solvent of hexane and ethyl acetate to give 7- [4'-fluoro-5,6-dimethoxy-3.
-(Propan-2-yl) biphenyl-2-yl]-
T-Butyl 3,5-O-isopropylidene-6-heptenoate (Compound (29)) was obtained in a yield of 157 mg and 78.0%.

【0096】融点:130.0〜131.0℃(無色針
状晶、酢酸エチルとヘキサンより再結晶)1 HNMR(300MHz,CDCl3 ) δ 0.82〜0.96 (m,1H),1.22 (d,
J=6.8Hz,3H),1.23 (d,J=6.8H
z,3H),1.18〜1.37 (m,1H),1.3
4 (s,3H),1.43 (s,3H),1.45
(s,9H),2.23(dd,J=15.3 and
6.2Hz,1H),2.39(dd,J=15.3
and 7.0Hz,1H),3.25(hept,
J=6.8Hz,1H),3.47 (s,3H),3.
91(s,3H),4.12〜4.28 (m,2H),
5.13(dd,J=16.2 and 6.2Hz,
1H),6.22(dd,J=16.2 and 1.
1Hz,1H),6.85(s,1H),6.96〜
7.06(m,2H),7.08〜7.20 (m,2
H)ppm IR(KBr):2968,1728,1604,15
88cm-1 Mass(m/z,%):528(M+ ,44),47
0(33),415 (31),414 (100),39
7 (43),371 (56),326 (39),311
(38),298(39),285 (84),283
(93)
Melting point: 130.0 to 131.0 ° C. (colorless needle crystals, recrystallized from ethyl acetate and hexane) 1 HNMR (300 MHz, CDCl 3 ) δ 0.82 to 0.96 (m, 1H), 1 .22 (d,
J = 6.8 Hz, 3H), 1.23 (d, J = 6.8H
z, 3H), 1.18 to 1.37 (m, 1H), 1.3
4 (s, 3H), 1.43 (s, 3H), 1.45
(S, 9H), 2.23 (dd, J = 15.3 and
6.2 Hz, 1 H), 2.39 (dd, J = 15.3)
and 7.0 Hz, 1H), 3.25 (hept,
J = 6.8 Hz, 1H), 3.47 (s, 3H), 3.
91 (s, 3H), 4.12 to 4.28 (m, 2H),
5.13 (dd, J = 16.2 and 6.2 Hz,
1H), 6.22 (dd, J = 16.2 and 1.
1Hz, 1H), 6.85 (s, 1H), 6.96 ~
7.06 (m, 2H), 7.08 to 7.20 (m, 2
H) ppm IR (KBr): 2968, 1728, 1604, 15
88 cm -1 Mass (m / z,%): 528 (M + , 44), 47
0 (33), 415 (31), 414 (100), 39
7 (43), 371 (56), 326 (39), 311
(38), 298 (39), 285 (84), 283
(93)

【0097】参考例20 ラット肝ステロール合成阻害作用の測定 参考例で合成した化合物についてヨーロッパ・ジャーナ
ル・バイオケミストリー(Eur.J.Bioche
m)77巻31頁(1977年)記載の方法に従い、体
重150〜200gのSD系ラットを用い、各化合物の
5%アラビアゴム懸濁溶液5ml/kgを経口投与し、
5時間後に14C−酢酸100μCi/kgを腹腔内投
与した。さらに1時間後、ラット屠殺し直ちに肝臓を取
り出し測定した。プラバスタチン及びシンバスタチンと
比較し結果を表1に示す。
Reference Example 20 Measurement of Rat Liver Sterol Synthesis Inhibitory Activity Regarding Compounds Synthesized in Reference Example European Journal Biochemistry (Eur. J. Bioche)
m) According to the method described in Vol. 77, p. 31 (1977), SD rats having a body weight of 150-200 g were orally administered with 5 ml / kg of a 5% gum arabic suspension solution of each compound,
Five hours later, 100 μCi / kg of 14 C-acetic acid was intraperitoneally administered. After 1 hour, the rat was sacrificed and the liver was immediately taken out and measured. The results are shown in Table 1 in comparison with pravastatin and simvastatin.

【0098】[0098]

【表1】 [Table 1]

【0099】[0099]

【発明の効果】本発明においては前記一般式(IV)で表
されるヘプタン酸誘導体と前記一般式(V)で表される
ハロゲン化合物から誘導される有機金属試薬とを反応さ
せたのち、脱水反応を行い前記一般式(II)で表される
カルボン酸エステル誘導体を製造することができる。こ
の前記一般式(II)で表されるカルボン酸エステル誘導
体は、例えば抗高脂血症剤などの医薬品の中間体として
有用な化合物である。
In the present invention, the heptanoic acid derivative represented by the general formula (IV) is reacted with the organometallic reagent derived from the halogen compound represented by the general formula (V), and then dehydrated. By carrying out a reaction, the carboxylic acid ester derivative represented by the general formula (II) can be produced. The carboxylic acid ester derivative represented by the general formula (II) is a compound useful as an intermediate for pharmaceuticals such as antihyperlipidemic agents.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07D 319/08 (72)発明者 小林 久子 東京都新宿区西新宿2丁目7番1号 富士 レビオ株式会社内 (72)発明者 伊川 博 東京都新宿区西新宿2丁目7番1号 富士 レビオ株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication location C07D 319/08 (72) Inventor Hisako Kobayashi 2-7-1, Nishishinjuku, Shinjuku-ku, Tokyo Fujirebio Co., Ltd. (72) Inventor Hiroshi Ikawa 2-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo Fuji Rebio Co., Ltd.

Claims (18)

【特許請求の範囲】[Claims] 【請求項1】 一般式 【化1】 で表されるヘプタン酸誘導体と一般式 R4 −X1 で表されるハロゲン化合物から誘導される有機金属試薬
とを反応させることからなる一般式 【化2】 で表されるカルボン酸エステル誘導体の製造方法(式
中、R1 及びR2 は水酸基の保護基又はR1 、R2 が一
体となった水酸基の保護基、R3 は、炭素数1〜12の
アルキル基又はアリール基、R4 は置換アリール基、置
換複素環基、置換ビニル基又は置換シクロアルケニル基
であり、X1はハロゲン原子である。)。
1. A general formula: A heptanoic acid derivative represented by the general formula R 4 —X 1 and an organometallic reagent derived from a halogen compound represented by the general formula R 4 —X 1. A method for producing a carboxylic acid ester derivative represented by the formula (wherein R 1 and R 2 are hydroxyl-protecting groups or a hydroxyl-protecting group in which R 1 and R 2 are integrated, and R 3 is a group having 1 to 12 carbon atoms. , An alkyl group or an aryl group, R 4 is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group or a substituted cycloalkenyl group, and X 1 is a halogen atom.).
【請求項2】 有機金属試薬を構成する金属がアルカリ
金属又はアルカリ土類金属である請求項1記載の方法。
2. The method according to claim 1, wherein the metal constituting the organometallic reagent is an alkali metal or an alkaline earth metal.
【請求項3】 有機金属試薬が有機リチウム化合物であ
る請求項2記載の方法。
3. The method according to claim 2, wherein the organometallic reagent is an organolithium compound.
【請求項4】 有機金属試薬が有機マグネシウムハライ
ド化合物である請求項2記載の方法。
4. The method according to claim 2, wherein the organometallic reagent is an organomagnesium halide compound.
【請求項5】 一般式 【化3】 で表されるカルボン酸エステル誘導体を脱水反応させる
ことからなる一般式 【化4】 で表されるカルボン酸エステル誘導体の製造方法(式
中、R1 及びR2 は水酸基の保護基又はR1 、R2 が一
体となった水酸基の保護基、R3 は炭素数1〜12のア
ルキル基又はアリール基、R4 は置換アリール基、置換
複素環基、置換ビニル基又は置換シクロアルケニル基で
ある。)。
5. A general formula: A general formula consisting of a dehydration reaction of a carboxylic acid ester derivative represented by: A method for producing a carboxylic acid ester derivative represented by the formula (wherein R 1 and R 2 are a hydroxyl group protecting group or a hydroxyl group protecting group in which R 1 and R 2 are integrated, and R 3 is a group having 1 to 12 carbon atoms. Alkyl group or aryl group, R 4 is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group or a substituted cycloalkenyl group.).
【請求項6】 脱水反応を、ハロゲン化試剤、スルホン
化試剤又はエステル化試剤の存在下に行う請求項5記載
の方法。
6. The method according to claim 5, wherein the dehydration reaction is carried out in the presence of a halogenating agent, a sulfonation agent or an esterification agent.
【請求項7】 脱水反応をハロゲン化試剤と塩基の存在
下に行う請求項6記載の方法。
7. The method according to claim 6, wherein the dehydration reaction is carried out in the presence of a halogenating agent and a base.
【請求項8】 一般式 【化5】 で表されるヘプタン酸誘導体と一般式R4 −X1 で表さ
れるハロゲン化合物から誘導される有機金属試薬とを反
応させて一般式 【化6】 で表されるカルボン酸エステル誘導体を得、次いで脱水
反応させることからなる一般式 【化7】 で表されるカルボン酸エステル誘導体の製造方法(式
中、R1 及びR2 は水酸基の保護基又はR1 、R2 が一
体となった水酸基の保護基、R3 は炭素数1〜12のア
ルキル基又はアリール基、R4 は置換アリール基、置換
複素環基、置換ビニル基又は置換シクロアルケニル基で
あり、X1 はハロゲン原子である。)。
8. A general formula: By reacting a heptanoic acid derivative represented by the formula with an organometallic reagent derived from a halogen compound represented by the formula R 4 —X 1. A carboxylic acid ester derivative represented by A method for producing a carboxylic acid ester derivative represented by the formula (wherein R 1 and R 2 are a hydroxyl group protecting group or a hydroxyl group protecting group in which R 1 and R 2 are integrated, and R 3 is a group having 1 to 12 carbon atoms. An alkyl group or an aryl group, R 4 is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group or a substituted cycloalkenyl group, and X 1 is a halogen atom.).
【請求項9】 有機金属試薬を構成する金属がアルカリ
金属又はアルカリ土類金属である請求項8記載の方法。
9. The method according to claim 8, wherein the metal constituting the organometallic reagent is an alkali metal or an alkaline earth metal.
【請求項10】 有機金属試薬が有機リチウム化合物で
ある請求項9記載の方法。
10. The method of claim 9, wherein the organometallic reagent is an organolithium compound.
【請求項11】 有機金属試薬が有機マグネシウムハラ
イドである請求項9記載の方法。
11. The method of claim 9 wherein the organometallic reagent is an organomagnesium halide.
【請求項12】 脱水反応をハロゲン化試剤、スルホン
化試剤又はエステル化試剤の存在下に行う請求項8記載
の方法。
12. The method according to claim 8, wherein the dehydration reaction is carried out in the presence of a halogenating agent, a sulfonation agent or an esterification agent.
【請求項13】 脱水反応をハロゲン化試剤と塩基の存
在下に行う請求項8記載の方法。
13. The method according to claim 8, wherein the dehydration reaction is carried out in the presence of a halogenating agent and a base.
【請求項14】 R1 及びR2 で表される水酸基の保護
基が炭素数1〜6のアルキル基、炭素数2〜6のアルケ
ニル基、複素環基、置換シリル基、アシル基、置換オキ
シカルボニル基若しくは置換カルバモイル基又はR1
2 が一体となった水酸基の保護基がメチレン基、炭素
数2〜10のアルキリデン基若しくはカルボニル基であ
る請求項1、5又は8のいづれかに記載の方法。
14. The hydroxyl-protecting group represented by R 1 and R 2 is an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a heterocyclic group, a substituted silyl group, an acyl group, a substituted oxy group. A carbonyl group or a substituted carbamoyl group or R 1 ,
The method according to any one of claims 1, 5 or 8, wherein the protective group for the hydroxyl group in which R 2 is integrated is a methylene group, an alkylidene group having 2 to 10 carbon atoms or a carbonyl group.
【請求項15】 R1 及びR2 で表される水酸基の保護
基が置換シリル基である請求項14記載の方法。
15. The method according to claim 14, wherein the protective group for the hydroxyl group represented by R 1 and R 2 is a substituted silyl group.
【請求項16】 R1 、R2 が一体となった水酸基の保
護基が炭素数2〜10のアルキリデン基である請求項1
4記載の方法。
16. The protective group for a hydroxyl group, in which R 1 and R 2 are integrated, is an alkylidene group having 2 to 10 carbon atoms.
4. The method described in 4.
【請求項17】 炭素数2〜10のアルキリデン基がイ
ソプロピリデン基又はシクロヘキシリデン基である請求
項16記載の方法。
17. The method according to claim 16, wherein the alkylidene group having 2 to 10 carbon atoms is an isopropylidene group or a cyclohexylidene group.
【請求項18】 R3 で表される炭素数1〜12のアル
キル基が、メチル基、エチル基、n−プロピル基、イソ
プロピル基、n−ブチル基、sec−ブチル基又はt−
ブチル基である請求項1、5又は8のいづれかに記載の
方法。
18. The alkyl group having 1 to 12 carbon atoms represented by R 3 is a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group or a t-group.
9. The method according to claim 1, which is a butyl group.
JP6207944A 1993-08-09 1994-08-09 Production of carboxylic acid ester derivative Pending JPH07101905A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6207944A JPH07101905A (en) 1993-08-09 1994-08-09 Production of carboxylic acid ester derivative

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5-214812 1993-08-09
JP21481293 1993-08-09
JP6207944A JPH07101905A (en) 1993-08-09 1994-08-09 Production of carboxylic acid ester derivative

Publications (1)

Publication Number Publication Date
JPH07101905A true JPH07101905A (en) 1995-04-18

Family

ID=26516554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6207944A Pending JPH07101905A (en) 1993-08-09 1994-08-09 Production of carboxylic acid ester derivative

Country Status (1)

Country Link
JP (1) JPH07101905A (en)

Similar Documents

Publication Publication Date Title
US5278313A (en) Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
HU208686B (en) Process for producing oxetanones
Solladie et al. Enantioselective synthesis of (+)-brefeldin A
JP2836556B2 (en) Method for producing intermediate of 5,6,7-trinor-4,8-inter-m-phenylene PG12 derivative
US4611068A (en) Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
US4855481A (en) Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
US4625039A (en) 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates
US5599952A (en) Methods of producing carboxylic acid ester derivatives and intermediates for use in the methods
Solladié et al. Enantioselective synthesis of C2-symmetric hexols from β, δ-diketosulfoxides
JPH07101905A (en) Production of carboxylic acid ester derivative
US5117039A (en) Monoesters of arylacetic acid and the process thereof
Islam et al. Synthesis of gerfelin and related analogous compounds
US4603213A (en) Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
JP3641420B2 (en) Process for producing 5-phthalanecarbonitrile compound, intermediate thereof and process for producing the same
JPH05339192A (en) Preparation of optically active cyclobutanone
US4499292A (en) 7-Oxabicycloheptane prostaglandin intermediates and method for preparing same
JP2719723B2 (en) Aryl acetic acid monoesters and their production
JP3410492B2 (en) 7-Octin-1-ene derivative and method for producing the same
JP2001247557A (en) Method of producing 5-oxy-7-oxabicyclo[4.1.0]hept-3-ene-3- carboxylic acid ester
US5504255A (en) Optically active compounds and a method for producing them
JP2986003B2 (en) 2-Alkyl-3-styryloxiranecarboxylic acid ester and method for producing the same
CA1273352A (en) Intermediates useful in the preparation of hmg-coa reductase inhibitors
JP2952487B2 (en) Optically active olefin lactone derivative and method for producing the same
US4861910A (en) Process for the production of substituted 2-oxocyclohexaneacetic acid esters
Michelet et al. Synthesis of natural products and biologically active compounds via allylpalladium and related derivatives